Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF2370 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1		1.1 A bill for an act
2		-	1.2 relating to cannabis; including the Office of Cannabis Management as an agency
3		-	1.3 for the purpose of having a government-to-government relationship with Tribal
4		-	1.4 governments; modifying provisions regarding the sale of cannabinoids derived
5		-	1.5 from hemp; modifying medical cannabis provisions; modifying hemp-derived
6		-	1.6 topical product provisions; modifying cannabis license application requirements;
7		-	1.7 modifying the limits of delta-9 tetrahydrocannabinol in edible cannabinoid products
8		-	1.8 and lower-potency hemp edibles when intended to be consumed as beverages;
9		-	1.9 allowing samples at cannabis events; amending Minnesota Statutes 2024, sections
10		-	1.10 10.65, subdivision 2; 151.72, subdivisions 3, 5a; 152.22, subdivisions 4, 7, 10, 13;
11		-	1.11 152.24; 152.25; 152.26; 152.261; 152.27, subdivisions 2, 7; 152.28, subdivisions
12		-	1.12 1, 3; 152.29, subdivisions 1, 2, 3a, 4; 152.31; 152.32, subdivision 2; 152.33,
13		-	1.13 subdivisions 1a, 4; 152.35; 152.37; 342.01, subdivisions 9, 47, 50, 71, by adding
14		-	1.14 subdivisions; 342.02, subdivision 3; 342.09, subdivision 2; 342.12; 342.14,
15		-	1.15 subdivisions 1, 3, 6; 342.151, subdivisions 2, 3; 342.22, subdivision 3; 342.28,
16		-	1.16 subdivisions 1, 8; 342.29, subdivisions 1, 7; 342.30, subdivision 1; 342.32,
17		-	1.17 subdivisions 4, 5; 342.33, subdivision 1; 342.40, subdivision 7, by adding a
18		-	1.18 subdivision; 342.43, by adding a subdivision; 342.44, subdivision 1; 342.45, by
19		-	1.19 adding a subdivision; 342.46, subdivision 6; 342.51, subdivision 2, by adding a
20		-	1.20 subdivision; 342.52, subdivision 9, by adding a subdivision; 342.56, subdivision
21		-	1.21 2; 342.57; 342.59, subdivision 2; 342.61, subdivision 4; 342.63, subdivisions 2,
22		-	1.22 3, 5, 6; 342.66, subdivision 6; repealing Minnesota Statutes 2024, sections 152.22,
23		-	1.23 subdivision 2; 342.151, subdivision 1.
24		-	1.24BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
25		-	1.25 Section 1. Minnesota Statutes 2024, section 10.65, subdivision 2, is amended to read:
26		-	1.26 Subd. 2.Definitions.As used in this section, the following terms have the meanings
27		-	1.27given:
28		-	1.28 (1) "agency" means the Department of Administration; Department of Agriculture;
29		-	1.29Department of Children, Youth, and Families; Department of Commerce; Department of
30		-	1.30Corrections; Department of Education; Department of Employment and Economic
31		-	1.31Development; Department of Health; Office of Higher Education; Housing Finance Agency;
	2	+	1.2 relating to cannabis; modifying the limits of delta-9 tetrahydrocannabinol in edible
	3	+	1.3 cannabinoid products and lower-potency hemp edibles when intended to be
	4	+	1.4 consumed as beverages; amending Minnesota Statutes 2024, sections 151.72,
	5	+	1.5 subdivision 5a; 342.01, subdivision 50; 342.46, subdivision 6.
	6	+	1.6BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
	7	+	1.7 Section 1. Minnesota Statutes 2024, section 151.72, subdivision 5a, is amended to read:
	8	+	1.8 Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition
	9	+	1.9to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid
	10	+	1.10must meet the requirements of this subdivision.
	11	+	1.11 (b) An edible cannabinoid product must not:
	12	+	1.12 (1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,
	13	+	1.13animal, or fruit that appeals to children;
	14	+	1.14 (2) be modeled after a brand of products primarily consumed by or marketed to children;
	15	+	1.15 (3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a
	16	+	1.16commercially available candy or snack food item;
	17	+	1.17 (4) be substantively similar to a meat food product; poultry food product as defined in
	18	+	1.18section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
	19	+	1.197;
	20	+	1.20 (5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved
	21	+	1.21by the United States Food and Drug Administration for use in food;
32	22		1Section 1.
33		-	~~S2370-1 1st Engrossment~~~~SF2370~~ REVISOR BD
	23	+	25-04139 as introduced02/19/25 REVISOR BD/MI
34	24		SENATE
35	25		STATE OF MINNESOTA
36	26		S.F. No. 2370NINETY-FOURTH SESSION
37	27		(SENATE AUTHORS: DIBBLE)
38	28		OFFICIAL STATUSD-PGDATE
39		-	Introduction and first reading71403/10/2025
40		-	Referred to Commerce and Consumer Protection
41		-	Comm report: To pass as amended04/03/2025
42		-	Second reading 2.1Department of Human Rights; Department of Human Services; Department of Information
43		-	2.2Technology Services; Department of Iron Range Resources and Rehabilitation; Department
44		-	2.3of Labor and Industry; Minnesota Management and Budget; Bureau of Mediation Services;
45		-	2.4Department of Military Affairs; Metropolitan Council; Department of Natural Resources;
46		-	2.5Pollution Control Agency; Department of Public Safety; Department of Revenue; Department
47		-	2.6of Transportation; Department of Veterans Affairs; Direct Care and Treatment; Gambling
48		-	2.7Control Board; Racing Commission; the Minnesota Lottery; the Animal Health Board; the
49		-	2.8Public Utilities Commission; and the Board of Water and Soil Resources; and the Office
50		-	2.9of Cannabis Management;
51		-	2.10 (2) "consultation" means the direct and interactive involvement of the Minnesota Tribal
52		-	2.11governments in the development of policy on matters that have Tribal implications.
53		-	2.12Consultation is the proactive, affirmative process of identifying and seeking input from
54		-	2.13appropriate Tribal governments and considering their interest as a necessary and integral
55		-	2.14part of the decision-making process. This definition adds to statutorily mandated notification
56		-	2.15procedures. During a consultation, the burden is on the agency to show that it has made a
57		-	2.16good faith effort to elicit feedback. Consultation is a formal engagement between agency
58		-	2.17officials and the governing body or bodies of an individual Minnesota Tribal government
59		-	2.18that the agency or an individual Tribal government may initiate. Formal meetings or
60		-	2.19communication between top agency officials and the governing body of a Minnesota Tribal
61		-	2.20government is a necessary element of consultation;
62		-	2.21 (3) "matters that have Tribal implications" means rules, legislative proposals, policy
63		-	2.22statements, or other actions that have substantial direct effects on one or more Minnesota
64		-	2.23Tribal governments, or on the distribution of power and responsibilities between the state
65		-	2.24and Minnesota Tribal governments;
66		-	2.25 (4) "Minnesota Tribal governments" means the federally recognized Indian Tribes located
67		-	2.26in Minnesota including: Bois Forte Band; Fond Du Lac Band; Grand Portage Band; Leech
68		-	2.27Lake Band; Mille Lacs Band; White Earth Band; Red Lake Nation; Lower Sioux Indian
69		-	2.28Community; Prairie Island Indian Community; Shakopee Mdewakanton Sioux Community;
70		-	2.29and Upper Sioux Community; and
71		-	2.30 (5) "timely and meaningful" means done or occurring at a favorable or useful time that
72		-	2.31allows the result of consultation to be included in the agency's decision-making process for
73		-	2.32a matter that has Tribal implications.
	29	+	Introduction and first reading03/10/2025
	30	+	Referred to Commerce and Consumer Protection 2.1 (6) be packaged in a way that resembles the trademarked, characteristic, or
	31	+	2.2product-specialized packaging of any commercially available food product; or
	32	+	2.3 (7) be packaged in a container that includes a statement, artwork, or design that could
	33	+	2.4reasonably mislead any person to believe that the package contains anything other than an
	34	+	2.5edible cannabinoid product.
	35	+	2.6 (c) An edible cannabinoid product must be prepackaged in packaging or a container that
	36	+	2.7is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is
	37	+	2.8child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The
	38	+	2.9requirement that packaging be child-resistant does not apply to an edible cannabinoid product
	39	+	2.10that is intended to be consumed as a beverage.
	40	+	2.11 (d) If an edible cannabinoid product, other than a product that is intended to be consumed
	41	+	2.12as a beverage, is intended for more than a single use or contains multiple servings, each
	42	+	2.13serving must be indicated by scoring, wrapping, or other indicators designating the individual
	43	+	2.14serving size that appear on the edible cannabinoid product. If it is not possible to indicate
	44	+	2.15a single serving by scoring or use of another indicator that appears on the product, the edible
	45	+	2.16cannabinoid product may not be packaged in a manner that includes more than a single
	46	+	2.17serving in each container, except that a calibrated dropper, measuring spoon, or similar
	47	+	2.18device for measuring a single serving, when sold with the product, may be used for any
	48	+	2.19edible cannabinoid products that are intended to be combined with food or beverage products
	49	+	2.20prior to consumption.
	50	+	2.21 (e) A label containing at least the following information must be affixed to the packaging
	51	+	2.22or container of all edible cannabinoid products sold to consumers:
	52	+	2.23 (1) the serving size;
	53	+	2.24 (2) the cannabinoid profile per serving and in total;
	54	+	2.25 (3) a list of ingredients, including identification of any major food allergens declared
	55	+	2.26by name; and
	56	+	2.27 (4) the following statement: "Keep this product out of reach of children."
	57	+	2.28 (f) An edible cannabinoid product must not contain more than five milligrams of any
	58	+	2.29tetrahydrocannabinol in a single serving, except that an edible cannabinoid product that is
	59	+	2.30intended to be consumed as a beverage may contain no more than ten milligrams of any
	60	+	2.31tetrahydrocannabinol in a single serving container. An edible cannabinoid product, other
	61	+	2.32than a product that is intended to be consumed as a beverage, may not contain more than a
	62	+	2.33total of 50 milligrams of any tetrahydrocannabinol per package. An edible cannabinoid
74	63		2Section 1.
75		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 3.1 Sec. 2. Minnesota Statutes 2024, section 151.72, subdivision 3, is amended to read:
76		-	3.2 Subd. 3.Sale of cannabinoids derived from hemp.(a) Notwithstanding any other
77		-	3.3section of this chapter, a product containing nonintoxicating cannabinoids, including an
78		-	3.4edible cannabinoid product, may be sold for human or animal consumption only if all of
79		-	3.5the requirements of this section are met. A product sold for human or animal consumption
80		-	3.6must not contain more than 0.3 percent of any tetrahydrocannabinol and an edible
81		-	3.7cannabinoid product must not contain an amount of any tetrahydrocannabinol that exceeds
82		-	3.8the limits established in subdivision 5a, paragraph (f).
83		-	3.9 (b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid
84		-	3.10product, may be sold for human or animal consumption only if it is intended for application
85		-	3.11externally to a part of the body of a human or animal. Such a product must not be
86		-	3.12manufactured, marketed, distributed, or intended to be consumed:
87		-	3.13 (1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or
88		-	3.14vapor from the product;
89		-	3.15 (2) through chewing, drinking, or swallowing; or
90		-	3.16 (3) through injection or application to nonintact skin or a mucous membrane or nonintact
91		-	3.17skin, except for products applied sublingually.
92		-	3.18 (c) No other substance extracted or otherwise derived from hemp may be sold for human
93		-	3.19consumption if the substance is intended:
94		-	3.20 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention
95		-	3.21of disease in humans or other animals; or
96		-	3.22 (2) to affect the structure or any function of the bodies of humans or other animals.
97		-	3.23 (d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise
98		-	3.24derived from hemp may be sold to any individual who is under the age of 21.
99		-	3.25 (e) Products that meet the requirements of this section are not controlled substances
100		-	3.26under section 152.02.
101		-	3.27 (f) Products may be sold for on-site consumption if all of the following conditions are
102		-	3.28met:
103		-	3.29 (1) the retailer must also hold an on-sale license issued under chapter 340A;
104		-	3.30 (2) products, other than products that are intended to be consumed as a beverage, must
105		-	3.31be served in original packaging, but may be removed from the products' packaging by
106		-	3.32customers and consumed on site;
	64	+	25-04139 as introduced02/19/25 REVISOR BD/MI 3.1product that is intended to be consumed as a beverage may not contain more than two
	65	+	3.2servings per container.
	66	+	3.3 (g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9
	67	+	3.4tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an
	68	+	3.5artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing
	69	+	3.6any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and
	70	+	3.7HHC, unless the office authorizes use of the artificially derived cannabinoid in edible
	71	+	3.8cannabinoid products. Edible cannabinoid products are prohibited from containing synthetic
	72	+	3.9cannabinoids.
	73	+	3.10 (h) Every person selling edible cannabinoid products to consumers, other than products
	74	+	3.11that are intended to be consumed as a beverage, must ensure that all edible cannabinoid
	75	+	3.12products are displayed behind a checkout counter where the public is not permitted or in a
	76	+	3.13locked case.
	77	+	3.14 Sec. 2. Minnesota Statutes 2024, section 342.01, subdivision 50, is amended to read:
	78	+	3.15 Subd. 50.Lower-potency hemp edible.(a) "Lower-potency hemp edible" means any
	79	+	3.16product that:
	80	+	3.17 (1) is intended to be eaten or consumed as a beverage by humans;
	81	+	3.18 (2) contains hemp concentrate or an artificially derived cannabinoid, in combination
	82	+	3.19with food ingredients;
	83	+	3.20 (3) is not a drug;
	84	+	3.21 (4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
	85	+	3.22 (5) is a type of product approved for sale by the office or is substantially similar to a
	86	+	3.23product approved by the office, including but not limited to products that resemble
	87	+	3.24nonalcoholic beverages, candy, and baked goods; and
	88	+	3.25 (6) meets either of the requirements in paragraph (b).
	89	+	3.26 (b) A lower-potency hemp edible includes:
	90	+	3.27 (1) a product that:
	91	+	3.28 (i) consists of servings that contain no more than five milligrams of delta-9
	92	+	3.29tetrahydrocannabinol; no more than 25 milligrams of cannabidiol, cannabigerol, cannabinol,
	93	+	3.30or cannabichromene; any other cannabinoid authorized by the office; or any combination
	94	+	3.31of those cannabinoids that does not exceed the identified amounts, except that a
107	95		3Sec. 2.
108		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 4.1 (3) products must not be sold to a customer who the retailer knows or reasonably should
109		-	4.2know is intoxicated;
110		-	4.3 (4) products must not be permitted to be mixed with an alcoholic beverage; and
111		-	4.4 (5) products that have been removed from packaging must not be removed from the
112		-	4.5premises.
113		-	4.6 (g) Edible cannabinoid products that are intended to be consumed as a beverage may be
114		-	4.7served outside of the products' packaging if the information that is required to be contained
115		-	4.8on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer.
116		-	4.9 Sec. 3. Minnesota Statutes 2024, section 151.72, subdivision 5a, is amended to read:
117		-	4.10 Subd. 5a.Additional requirements for edible cannabinoid products.(a) In addition
118		-	4.11to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid
119		-	4.12must meet the requirements of this subdivision.
120		-	4.13 (b) An edible cannabinoid product must not:
121		-	4.14 (1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,
122		-	4.15animal, or fruit that appeals to children;
123		-	4.16 (2) be modeled after a brand of products primarily consumed by or marketed to children;
124		-	4.17 (3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a
125		-	4.18commercially available candy or snack food item;
126		-	4.19 (4) be substantively similar to a meat food product; poultry food product as defined in
127		-	4.20section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
128		-	4.217;
129		-	4.22 (5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved
130		-	4.23by the United States Food and Drug Administration for use in food;
131		-	4.24 (6) be packaged in a way that resembles the trademarked, characteristic, or
132		-	4.25product-specialized packaging of any commercially available food product; or
133		-	4.26 (7) be packaged in a container that includes a statement, artwork, or design that could
134		-	4.27reasonably mislead any person to believe that the package contains anything other than an
135		-	4.28edible cannabinoid product.
136		-	4.29 (c) An edible cannabinoid product must be prepackaged in packaging or a container that
137		-	4.30is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is
138		-	4.31child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The
	96	+	25-04139 as introduced02/19/25 REVISOR BD/MI 4.1lower-potency hemp edible that is intended to be consumed as a beverage may contain no
	97	+	4.2more than ten milligrams of delta-9 tetrahydrocannabinol in a single serving container;
	98	+	4.3 (ii) does not contain more than a combined total of 0.5 milligrams of all other
	99	+	4.4cannabinoids per serving; and
	100	+	4.5 (iii) does not contain an artificially derived cannabinoid other than delta-9
	101	+	4.6tetrahydrocannabinol, except that a product may include artificially derived cannabinoids
	102	+	4.7created during the process of creating the delta-9 tetrahydrocannabinol that is added to the
	103	+	4.8product, if no artificially derived cannabinoid is added to the ingredient containing delta-9
	104	+	4.9tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially
	105	+	4.10derived cannabinoids is no less than 20 to one; or
	106	+	4.11 (2) a product that:
	107	+	4.12 (i) contains hemp concentrate processed or refined without increasing the percentage of
	108	+	4.13targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp
	109	+	4.14plant or hemp plant parts beyond the variability generally recognized for the method used
	110	+	4.15for processing or refining or by an amount needed to reduce the total THC in the hemp
	111	+	4.16concentrate; and
	112	+	4.17 (ii) consists of servings that contain no more than five milligrams of total THC.
	113	+	4.18 Sec. 3. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
	114	+	4.19 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure
	115	+	4.20that all lower-potency hemp edibles offered for sale comply with the limits on the amount
	116	+	4.21and types of cannabinoids that a lower-potency hemp edible can contain, including but not
	117	+	4.22limited to the requirement that lower-potency hemp edibles:
	118	+	4.23 (1) consist of servings that contain no more than five milligrams of delta-9
	119	+	4.24tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams
	120	+	4.25of cannabigerol, or any combination of those cannabinoids that does not exceed the identified
	121	+	4.26amounts, except that a lower-potency hemp edible that is intended to be consumed as a
	122	+	4.27beverage may contain no more than ten milligrams of delta-9 tetrahydrocannabinol in a
	123	+	4.28single serving container;
	124	+	4.29 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids
	125	+	4.30per serving; and
	126	+	4.31 (3) do not contain an artificially derived cannabinoid other than delta-9
	127	+	4.32tetrahydrocannabinol.
139	128		4Sec. 3.
140		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 5.1requirement that packaging be child-resistant does not apply to an edible cannabinoid product
141		-	5.2that is intended to be consumed as a beverage.
142		-	5.3 (d) If an edible cannabinoid product, other than a product that is intended to be consumed
143		-	5.4as a beverage, is intended for more than a single use or contains multiple servings, each
144		-	5.5serving must be indicated by scoring, wrapping, or other indicators designating the individual
145		-	5.6serving size that appear on the edible cannabinoid product. If it is not possible to indicate
146		-	5.7a single serving by scoring or use of another indicator that appears on the product, the edible
147		-	5.8cannabinoid product may not be packaged in a manner that includes more than a single
148		-	5.9serving in each container, except that a calibrated dropper, measuring spoon, or similar
149		-	5.10device for measuring a single serving, when sold with the product, may be used for any
150		-	5.11edible cannabinoid products that are intended to be combined with food or beverage products
151		-	5.12prior to consumption.
152		-	5.13 (e) A label containing at least the following information must be affixed to the packaging
153		-	5.14or container of all edible cannabinoid products sold to consumers:
154		-	5.15 (1) the serving size;
155		-	5.16 (2) the cannabinoid profile per serving and in total;
156		-	5.17 (3) a list of ingredients, including identification of any major food allergens declared
157		-	5.18by name; and
158		-	5.19 (4) the following statement: "Keep this product out of reach of children."
159		-	5.20 (f) An edible cannabinoid product must not contain more than five milligrams of any
160		-	5.21tetrahydrocannabinol in a single serving, except that an edible cannabinoid product that is
161		-	5.22intended to be consumed as a beverage may contain no more than ten milligrams of any
162		-	5.23tetrahydrocannabinol in a single-serving container. An edible cannabinoid product, other
163		-	5.24than a product that is intended to be consumed as a beverage, may not contain more than a
164		-	5.25total of 50 milligrams of any tetrahydrocannabinol per package. An edible cannabinoid
165		-	5.26product that is intended to be consumed as a beverage may not contain more than two
166		-	5.27servings per container.
167		-	5.28 (g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9
168		-	5.29tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an
169		-	5.30artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing
170		-	5.31any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and
171		-	5.32HHC, unless the office authorizes use of the artificially derived cannabinoid in edible
	129	+	25-04139 as introduced02/19/25 REVISOR BD/MI 5.1 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a
	130	+	5.2single serving, the lower-potency hemp edible must indicate each serving by scoring,
	131	+	5.3wrapping, or other indicators that appear on the lower-potency hemp edible designating the
	132	+	5.4individual serving size. If it is not possible to indicate a single serving by scoring or use of
	133	+	5.5another indicator that appears on the product, the lower-potency hemp edible may not be
	134	+	5.6packaged in a manner that includes more than a single serving in each container, except
	135	+	5.7that a calibrated dropper, measuring spoon, or similar device for measuring a single serving
	136	+	5.8may be used for any edible cannabinoid products that are intended to be combined with
	137	+	5.9food or beverage products prior to consumption. If the lower-potency hemp edible is meant
	138	+	5.10to be consumed as a beverage, the beverage container may not contain more than two
	139	+	5.11servings per container.
	140	+	5.12 (c) A single package containing multiple servings of a lower-potency hemp edible must
	141	+	5.13contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of
	142	+	5.14cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that
	143	+	5.15does not exceed the identified amounts.
172	144		5Sec. 3.
173		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 6.1cannabinoid products. Edible cannabinoid products are prohibited from containing synthetic
174		-	6.2cannabinoids.
175		-	6.3 (h) Every person selling edible cannabinoid products to consumers, other than products
176		-	6.4that are intended to be consumed as a beverage, must ensure that all edible cannabinoid
177		-	6.5products are displayed behind a checkout counter where the public is not permitted or in a
178		-	6.6locked case.
179		-	6.7 Sec. 4. Minnesota Statutes 2024, section 152.22, subdivision 4, is amended to read:
180		-	6.8 Subd. 4.Health care practitioner."Health care practitioner" means a Minnesota licensed
181		-	6.9Minnesota-licensed doctor of medicine, a Minnesota licensed Minnesota-licensed physician
182		-	6.10assistant acting within the scope of authorized practice, or a Minnesota licensed
183		-	6.11Minnesota-licensed advanced practice registered nurse who has an active license in good
184		-	6.12standing and the primary responsibility for the care and treatment of the qualifying medical
185		-	6.13condition of a person an individual diagnosed with a qualifying medical condition.
186		-	6.14 Sec. 5. Minnesota Statutes 2024, section 152.22, subdivision 7, is amended to read:
187		-	6.15 Subd. 7.Medical cannabis manufacturer."Medical cannabis manufacturer" or
188		-	6.16"manufacturer" means an entity registered by the commissioner office to cultivate, acquire,
189		-	6.17manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis,
190		-	6.18delivery devices, or related supplies and educational materials.
191		-	6.19 Sec. 6. Minnesota Statutes 2024, section 152.22, subdivision 10, is amended to read:
192		-	6.20 Subd. 10.Patient registry number."Patient registry number" means a unique
193		-	6.21identification number assigned by the commissioner office to a patient enrolled in the registry
194		-	6.22program.
195		-	6.23 Sec. 7. Minnesota Statutes 2024, section 152.22, subdivision 13, is amended to read:
196		-	6.24 Subd. 13.Registry verification."Registry verification" means the verification provided
197		-	6.25by the commissioner office that a patient is enrolled in the registry program and that includes
198		-	6.26the patient's name, registry number, and, if applicable, the name of the patient's registered
199		-	6.27designated caregiver or parent, legal guardian, or spouse.
200		-	6Sec. 7.
201		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 7.1 Sec. 8. Minnesota Statutes 2024, section 152.24, is amended to read:
202		-	7.2 152.24 FEDERALLY APPROVED CLINICAL TRIALS.
203		-	7.3 The commissioner office may prohibit enrollment of a patient in the registry program
204		-	7.4if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment
205		-	7.5of a qualifying medical condition with medical cannabis. The commissioner office shall
206		-	7.6provide information to all patients enrolled in the registry program on the existence of
207		-	7.7federally approved clinical trials for the treatment of the patient's qualifying medical condition
208		-	7.8with medical cannabis as an alternative to enrollment in the patient registry program.
209		-	7.9 Sec. 9. Minnesota Statutes 2024, section 152.25, is amended to read:
210		-	7.10 152.25 COMMISSIONER OFFICE DUTIES.
211		-	7.11 Subdivision 1.Medical cannabis manufacturer registration.(a) The commissioner
212		-	7.12office shall register two in-state manufacturers for the production of all medical cannabis
213		-	7.13within the state. A registration agreement between the commissioner office and a
214		-	7.14manufacturer is nontransferable. The commissioner office shall register new manufacturers
215		-	7.15or reregister the existing manufacturers by December 1 every two years, using the factors
216		-	7.16described in this subdivision. The commissioner office shall accept applications after
217		-	7.17December 1, 2014, if one of the manufacturers registered before December 1, 2014, ceases
218		-	7.18to be registered as a manufacturer. The commissioner's office's determination that no
219		-	7.19manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial
220		-	7.20review in Ramsey County District Court. Data submitted during the application process are
221		-	7.21private data on individuals or nonpublic data as defined in section 13.02 until the
222		-	7.22manufacturer is registered under this section. Data on a manufacturer that is registered are
223		-	7.23public data, unless the data are trade secret or security information under section 13.37.
224		-	7.24 (b) As a condition for registration, a manufacturer must agree to:
225		-	7.25 (1) begin supplying medical cannabis to patients by July 1, 2015; and
226		-	7.26 (2) comply with all requirements under sections 152.22 to 152.37.
227		-	7.27 (c) The commissioner office shall consider the following factors when determining
228		-	7.28which manufacturer to register:
229		-	7.29 (1) the technical expertise of the manufacturer in cultivating medical cannabis and
230		-	7.30converting the medical cannabis into an acceptable delivery method under section 152.22,
231		-	7.31subdivision 6;
232		-	7.32 (2) the qualifications of the manufacturer's employees;
233		-	7Sec. 9.
234		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 8.1 (3) the long-term financial stability of the manufacturer;
235		-	8.2 (4) the ability to provide appropriate security measures on the premises of the
236		-	8.3manufacturer;
237		-	8.4 (5) whether the manufacturer has demonstrated an ability to meet the medical cannabis
238		-	8.5production needs required by sections 152.22 to 152.37; and
239		-	8.6 (6) the manufacturer's projection and ongoing assessment of fees on patients with a
240		-	8.7qualifying medical condition.
241		-	8.8 (d) If an officer, director, or controlling person of the manufacturer pleads or is found
242		-	8.9guilty of intentionally diverting medical cannabis to a person other than allowed by law
243		-	8.10under section 152.33, subdivision 1, the commissioner office may decide not to renew the
244		-	8.11registration of the manufacturer, provided the violation occurred while the person was an
245		-	8.12officer, director, or controlling person of the manufacturer.
246		-	8.13 (e) The commissioner office shall require each medical cannabis manufacturer to contract
247		-	8.14with an independent laboratory to test medical cannabis produced by the manufacturer. The
248		-	8.15commissioner office shall approve the laboratory chosen by each manufacturer and require
249		-	8.16that the laboratory report testing results to the manufacturer in a manner determined by the
250		-	8.17commissioner office.
251		-	8.18 Subd. 1a.Revocation or nonrenewal of a medical cannabis manufacturer
252		-	8.19registration.If the commissioner office intends to revoke or not renew a registration issued
253		-	8.20under this section, the commissioner office must first notify in writing the manufacturer
254		-	8.21against whom the action is to be taken and provide the manufacturer with an opportunity
255		-	8.22to request a hearing under the contested case provisions of chapter 14. If the manufacturer
256		-	8.23does not request a hearing by notifying the commissioner office in writing within 20 days
257		-	8.24after receipt of the notice of proposed action, the commissioner office may proceed with
258		-	8.25the action without a hearing. For revocations, the registration of a manufacturer is considered
259		-	8.26revoked on the date specified in the commissioner's office's written notice of revocation.
260		-	8.27 Subd. 1b.Temporary suspension proceedings.The commissioner office may institute
261		-	8.28proceedings to temporarily suspend the registration of a medical cannabis manufacturer for
262		-	8.29a period of up to 90 days by notifying the manufacturer in writing if any action by an
263		-	8.30employee, agent, officer, director, or controlling person of the manufacturer:
264		-	8.31 (1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted
265		-	8.32thereunder;
266		-	8Sec. 9.
267		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 9.1 (2) permits, aids, or abets the commission of any violation of state law at the
268		-	9.2manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing
269		-	9.3or at any site for distribution of medical cannabis;
270		-	9.4 (3) performs any act contrary to the welfare of a registered patient or registered designated
271		-	9.5caregiver; or
272		-	9.6 (4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.
273		-	9.7 Subd. 1c.Notice to patients.Upon the revocation or nonrenewal of a manufacturer's
274		-	9.8registration under subdivision 1a or implementation of an enforcement action under
275		-	9.9subdivision 1b that may affect the ability of a registered patient, registered designated
276		-	9.10caregiver, or a registered patient's parent, legal guardian, or spouse to obtain medical cannabis
277		-	9.11from the manufacturer subject to the enforcement action, the commissioner office shall
278		-	9.12notify in writing each registered patient and the patient's registered designated caregiver or
279		-	9.13registered patient's parent, legal guardian, or spouse about the outcome of the proceeding
280		-	9.14and information regarding alternative registered manufacturers. This notice must be provided
281		-	9.15two or more business days prior to the effective date of the revocation, nonrenewal, or other
282		-	9.16enforcement action.
283		-	9.17 Subd. 2.Range of compounds and dosages; report.The office shall review and publicly
284		-	9.18report the existing medical and scientific literature regarding the range of recommended
285		-	9.19dosages for each qualifying condition and the range of chemical compositions of any plant
286		-	9.20of the genus cannabis that will likely be medically beneficial for each of the qualifying
287		-	9.21medical conditions. The office shall make this information available to patients with
288		-	9.22qualifying medical conditions beginning December 1, 2014, and update the information
289		-	9.23every three years. The office may consult with the independent laboratory under contract
290		-	9.24with the manufacturer or other experts in reporting the range of recommended dosages for
291		-	9.25each qualifying medical condition, the range of chemical compositions that will likely be
292		-	9.26medically beneficial, and any risks of noncannabis drug interactions. The office shall consult
293		-	9.27with each manufacturer on an annual basis on medical cannabis offered by the manufacturer.
294		-	9.28The list of medical cannabis offered by a manufacturer shall be published on the Office of
295		-	9.29Cannabis Management website.
296		-	9.30 Subd. 3.Deadlines.The commissioner office shall adopt rules necessary for the
297		-	9.31manufacturer to begin distribution of medical cannabis to patients under the registry program
298		-	9.32by July 1, 2015, and have notice of proposed rules published in the State Register prior to
299		-	9.33January 1, 2015.
300		-	9Sec. 9.
301		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 10.1 Subd. 4.Reports.(a) The commissioner office shall provide regular updates to the task
302		-	10.2force on medical cannabis therapeutic research and; to the chairs and ranking minority
303		-	10.3members of the legislative committees with jurisdiction over health and human services,
304		-	10.4public safety, judiciary, and civil law; and to the Cannabis Advisory Council under section
305		-	10.5342.03 regarding: (1) any changes in federal law or regulatory restrictions regarding the
306		-	10.6use of medical cannabis or hemp; and (2) the market demand and supply in this state for
307		-	10.7products made from hemp that can be used for medicinal purposes.
308		-	10.8 (b) The commissioner office may submit medical research based on the data collected
309		-	10.9under sections 152.22 to 152.37 to any federal agency with regulatory or enforcement
310		-	10.10authority over medical cannabis to demonstrate the effectiveness of medical cannabis for
311		-	10.11treating a qualifying medical condition.
312		-	10.12Sec. 10. Minnesota Statutes 2024, section 152.26, is amended to read:
313		-	10.13 152.26 RULEMAKING.
314		-	10.14 (a) The commissioner office may adopt rules to implement sections 152.22 to 152.37.
315		-	10.15Rules for which notice is published in the State Register before January 1, 2015, may be
316		-	10.16adopted using the process in section 14.389.
317		-	10.17 (b) The commissioner office may adopt or amend rules, using the procedure in section
318		-	10.1814.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form
319		-	10.19of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section
320		-	10.2014.386, paragraph (b), does not apply to these rules.
321		-	10.21Sec. 11. Minnesota Statutes 2024, section 152.261, is amended to read:
322		-	10.22 152.261 RULES; ADVERSE INCIDENTS.
323		-	10.23 (a) The commissioner of health office shall adopt rules to establish requirements for
324		-	10.24reporting incidents when individuals who are not authorized to possess medical cannabis
325		-	10.25under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules
326		-	10.26must identify professionals required to report, the information they are required to report,
327		-	10.27and actions the reporter must take to secure the medical cannabis.
328		-	10.28 (b) The commissioner of health office shall adopt rules to establish requirements for law
329		-	10.29enforcement officials and health care professionals to report incidents involving an overdose
330		-	10.30of medical cannabis to the commissioner of health office.
331		-	10.31 (c) Rules must include the method by which the commissioner office will collect and
332		-	10.32tabulate reports of unauthorized possession and overdose.
333		-	10Sec. 11.
334		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 11.1 Sec. 12. Minnesota Statutes 2024, section 152.27, subdivision 2, is amended to read:
335		-	11.2 Subd. 2.Office duties.(a) The office shall:
336		-	11.3 (1) give notice of the program to health care practitioners in the state who are eligible
337		-	11.4to serve as health care practitioners and explain the purposes and requirements of the
338		-	11.5program;
339		-	11.6 (2) allow each health care practitioner who meets or agrees to meet the program's
340		-	11.7requirements and who requests to participate, to be included in the registry program to
341		-	11.8collect data for the patient registry;
342		-	11.9 (3) provide explanatory information and assistance to each health care practitioner in
343		-	11.10understanding the nature of therapeutic use of medical cannabis within program requirements;
344		-	11.11 (4) create and provide a certification to be used by a health care practitioner for the
345		-	11.12practitioner to certify whether a patient has been diagnosed with a qualifying medical
346		-	11.13condition;
347		-	11.14 (5) supervise the participation of the health care practitioner in conducting patient
348		-	11.15treatment and health records reporting in a manner that ensures stringent security and
349		-	11.16record-keeping requirements and that prevents the unauthorized release of private data on
350		-	11.17individuals as defined by section 13.02;
351		-	11.18 (6) develop safety criteria for patients with a qualifying medical condition as a
352		-	11.19requirement of the patient's participation in the program, to prevent the patient from
353		-	11.20undertaking any task under the influence of medical cannabis that would constitute negligence
354		-	11.21or professional malpractice on the part of the patient; and
355		-	11.22 (7) conduct research and studies based on data from health records submitted to the
356		-	11.23registry program and submit reports on intermediate or final research results to the legislature
357		-	11.24and major scientific journals. The office may contract with a third party to complete the
358		-	11.25requirements of this clause. Any reports submitted must comply with section 152.28,
359		-	11.26subdivision 2.
360		-	11.27 (b) The office may add a delivery method under section 152.22, subdivision 6, upon a
361		-	11.28petition from a member of the public or the Cannabis Advisory Council under section 342.03
362		-	11.29or as directed by law. If the office wishes to add a delivery method under section 152.22,
363		-	11.30subdivision 6, the office must notify the chairs and ranking minority members of the
364		-	11.31legislative policy committees having jurisdiction over health and public safety of the addition
365		-	11.32and the reasons for its addition, including any written comments received by the office from
366		-	11.33the public and any guidance received from the Cannabis Advisory Council under section
367		-	11Sec. 12.
368		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 12.1342.03, by January 15 of the year in which the office wishes to make the change. The change
369		-	12.2shall be effective on August 1 of that year, unless the legislature by law provides otherwise.
370		-	12.3 Sec. 13. Minnesota Statutes 2024, section 152.27, subdivision 7, is amended to read:
371		-	12.4 Subd. 7.Notice requirements.Patients and registered designated caregivers shall notify
372		-	12.5the commissioner office of any address or name change within 30 days of the change having
373		-	12.6occurred. A patient or registered designated caregiver is subject to a $100 fine for failure
374		-	12.7to notify the commissioner office of the change.
375		-	12.8 Sec. 14. Minnesota Statutes 2024, section 152.28, subdivision 1, is amended to read:
376		-	12.9 Subdivision 1.Health care practitioner duties.(a) Prior to a patient's enrollment in
377		-	12.10the registry program, a health care practitioner shall:
378		-	12.11 (1) determine, in the health care practitioner's medical judgment, whether a patient suffers
379		-	12.12from a qualifying medical condition, and, if so determined, provide the patient with a
380		-	12.13certification of that diagnosis;
381		-	12.14 (2) advise patients, registered designated caregivers, and parents, legal guardians, or
382		-	12.15spouses who are acting as caregivers of the existence of any nonprofit patient support groups
383		-	12.16or organizations;
384		-	12.17 (3) provide explanatory information from the office to patients with qualifying medical
385		-	12.18conditions, including disclosure to all patients about the experimental nature of therapeutic
386		-	12.19use of medical cannabis; the possible risks, benefits, and side effects of the proposed
387		-	12.20treatment; the application and other materials from the office; and provide patients with the
388		-	12.21Tennessen warning as required by section 13.04, subdivision 2; and
389		-	12.22 (4) agree to continue treatment of the patient's qualifying medical condition and report
390		-	12.23medical findings to the office.
391		-	12.24 (b) Upon notification from the office of the patient's enrollment in the registry program,
392		-	12.25the health care practitioner shall:
393		-	12.26 (1) participate in the patient registry reporting system under the guidance and supervision
394		-	12.27of the office;
395		-	12.28 (2) report health records of the patient throughout the ongoing treatment of the patient
396		-	12.29to the office in a manner determined by the commissioner office and in accordance with
397		-	12.30subdivision 2;
398		-	12Sec. 14.
399		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 13.1 (3) determine, every three years, if the patient continues to suffer from a qualifying
400		-	13.2medical condition and, if so, issue the patient a new certification of that diagnosis; and
401		-	13.3 (4) otherwise comply with all requirements developed by the office.
402		-	13.4 (c) A health care practitioner may utilize telehealth, as defined in section 62A.673,
403		-	13.5subdivision 2, for certifications and recertifications.
404		-	13.6 (d) Nothing in this section requires a health care practitioner to participate in the registry
405		-	13.7program.
406		-	13.8 Sec. 15. Minnesota Statutes 2024, section 152.28, subdivision 3, is amended to read:
407		-	13.9 Subd. 3.Advertising restrictions.(a) A health care practitioner shall not publish or
408		-	13.10cause to be published any advertisement that:
409		-	13.11 (1) contains false or misleading statements about medical cannabis or about the medical
410		-	13.12cannabis registry program;
411		-	13.13 (2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;
412		-	13.14 (3) states or implies the health care practitioner is endorsed by the Department of Health
413		-	13.15office or by the medical cannabis registry program;
414		-	13.16 (4) includes images of cannabis in its plant or leaf form or of cannabis-smoking
415		-	13.17paraphernalia; or
416		-	13.18 (5) contains medical symbols that could reasonably be confused with symbols of
417		-	13.19established medical associations or groups.
418		-	13.20 (b) A health care practitioner found by the commissioner office to have violated this
419		-	13.21subdivision is prohibited from certifying that patients have a qualifying medical condition
420		-	13.22for purposes of patient participation in the registry program. The commissioner's office's
421		-	13.23decision that a health care practitioner has violated this subdivision is a final decision of
422		-	13.24the commissioner office and is not subject to the contested case procedures in chapter 14.
423		-	13.25Sec. 16. Minnesota Statutes 2024, section 152.29, subdivision 1, is amended to read:
424		-	13.26 Subdivision 1.Manufacturer; requirements.(a) A manufacturer may operate eight
425		-	13.27distribution facilities, which may include the manufacturer's single location for cultivation,
426		-	13.28harvesting, manufacturing, packaging, and processing but is not required to include that
427		-	13.29location. The commissioner office shall designate the geographical service areas to be served
428		-	13.30by each manufacturer based on geographical need throughout the state to improve patient
429		-	13.31access. A manufacturer shall not have more than two distribution facilities in each
430		-	13Sec. 16.
431		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 14.1geographical service area assigned to the manufacturer by the commissioner office. A
432		-	14.2manufacturer shall operate only one location where all cultivation, harvesting, manufacturing,
433		-	14.3packaging, and processing of medical cannabis shall be conducted. This location may be
434		-	14.4one of the manufacturer's distribution facility sites. The additional distribution facilities
435		-	14.5may dispense medical cannabis and medical cannabis products but may not contain any
436		-	14.6medical cannabis in a form other than those forms allowed under section 152.22, subdivision
437		-	14.76, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing,
438		-	14.8packaging, or processing at the other distribution facility sites. Any distribution facility
439		-	14.9operated by the manufacturer is subject to all of the requirements applying to the
440		-	14.10manufacturer under sections 152.22 to 152.37, including, but not limited to, security and
441		-	14.11distribution requirements.
442		-	14.12 (b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may
443		-	14.13acquire hemp products produced by a hemp processor. A manufacturer may manufacture
444		-	14.14or process hemp and hemp products into an allowable form of medical cannabis under
445		-	14.15section 152.22, subdivision 6. Hemp and hemp products acquired by a manufacturer under
446		-	14.16this paragraph are subject to the same quality control program, security and testing
447		-	14.17requirements, and other requirements that apply to medical cannabis under sections 152.22
448		-	14.18to 152.37 and Minnesota Rules, chapter 4770.
449		-	14.19 (c) A medical cannabis manufacturer shall contract with a laboratory approved by the
450		-	14.20commissioner office, subject to any additional requirements set by the commissioner office,
451		-	14.21for purposes of testing medical cannabis manufactured or hemp or hemp products acquired
452		-	14.22by the medical cannabis manufacturer as to content, contamination, and consistency to
453		-	14.23verify the medical cannabis meets the requirements of section 152.22, subdivision 6. The
454		-	14.24cost of laboratory testing shall be paid by the manufacturer.
455		-	14.25 (d) The operating documents of a manufacturer must include:
456		-	14.26 (1) procedures for the oversight of the manufacturer and procedures to ensure accurate
457		-	14.27record keeping;
458		-	14.28 (2) procedures for the implementation of appropriate security measures to deter and
459		-	14.29prevent the theft of medical cannabis and unauthorized entrance into areas containing medical
460		-	14.30cannabis; and
461		-	14.31 (3) procedures for the delivery and transportation of hemp between hemp growers and
462		-	14.32manufacturers and for the delivery and transportation of hemp products between hemp
463		-	14.33processors and manufacturers.
464		-	14Sec. 16.
465		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 15.1 (e) A manufacturer shall implement security requirements, including requirements for
466		-	15.2the delivery and transportation of hemp and hemp products, protection of each location by
467		-	15.3a fully operational security alarm system, facility access controls, perimeter intrusion
468		-	15.4detection systems, and a personnel identification system.
469		-	15.5 (f) A manufacturer shall not share office space with, refer patients to a health care
470		-	15.6practitioner, or have any financial relationship with a health care practitioner.
471		-	15.7 (g) A manufacturer shall not permit any person to consume medical cannabis on the
472		-	15.8property of the manufacturer.
473		-	15.9 (h) A manufacturer is subject to reasonable inspection by the commissioner office.
474		-	15.10 (i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not
475		-	15.11subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.
476		-	15.12 (j) A medical cannabis manufacturer may not employ any person who is under 21 years
477		-	15.13of age or who has been convicted of a disqualifying felony offense. An employee of a
478		-	15.14medical cannabis manufacturer must submit a completed criminal history records check
479		-	15.15consent form, a full set of classifiable fingerprints, and the required fees for submission to
480		-	15.16the Bureau of Criminal Apprehension before an employee may begin working with the
481		-	15.17manufacturer. The bureau must conduct a Minnesota criminal history records check and
482		-	15.18the superintendent is authorized to exchange the fingerprints with the Federal Bureau of
483		-	15.19Investigation to obtain the applicant's national criminal history record information. The
484		-	15.20bureau shall return the results of the Minnesota and federal criminal history records checks
485		-	15.21to the commissioner office.
486		-	15.22 (k) A manufacturer may not operate in any location, whether for distribution or
487		-	15.23cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a
488		-	15.24public or private school existing before the date of the manufacturer's registration with the
489		-	15.25commissioner office.
490		-	15.26 (l) A manufacturer shall comply with reasonable restrictions set by the commissioner
491		-	15.27office relating to signage, marketing, display, and advertising of medical cannabis.
492		-	15.28 (m) Before a manufacturer acquires hemp from a hemp grower or hemp products from
493		-	15.29a hemp processor, the manufacturer must verify that the hemp grower or hemp processor
494		-	15.30has a valid license issued by the commissioner of agriculture under chapter 18K.
495		-	15.31 (n) Until a state-centralized, seed-to-sale system is implemented that can track a specific
496		-	15.32medical cannabis plant from cultivation through testing and point of sale, the commissioner
497		-	15Sec. 16.
498		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 16.1office shall conduct at least one unannounced inspection per year of each manufacturer that
499		-	16.2includes inspection of:
500		-	16.3 (1) business operations;
501		-	16.4 (2) physical locations of the manufacturer's manufacturing facility and distribution
502		-	16.5facilities;
503		-	16.6 (3) financial information and inventory documentation, including laboratory testing
504		-	16.7results; and
505		-	16.8 (4) physical and electronic security alarm systems.
506		-	16.9 Sec. 17. Minnesota Statutes 2024, section 152.29, subdivision 2, is amended to read:
507		-	16.10 Subd. 2.Manufacturer; production.(a) A manufacturer of medical cannabis shall
508		-	16.11provide a reliable and ongoing supply of all medical cannabis needed for the registry program
509		-	16.12through cultivation by the manufacturer and through the purchase of hemp from hemp
510		-	16.13growers.
511		-	16.14 (b) All cultivation, harvesting, manufacturing, packaging, and processing of medical
512		-	16.15cannabis must take place in an enclosed, locked facility at a physical address provided to
513		-	16.16the commissioner office during the registration process.
514		-	16.17 (c) A manufacturer must process and prepare any medical cannabis plant material or
515		-	16.18hemp plant material into a form allowable under section 152.22, subdivision 6, prior to
516		-	16.19distribution of any medical cannabis.
517		-	16.20Sec. 18. Minnesota Statutes 2024, section 152.29, subdivision 3a, is amended to read:
518		-	16.21 Subd. 3a.Transportation of medical cannabis; transport staffing.(a) A medical
519		-	16.22cannabis manufacturer may staff a transport motor vehicle with only one employee if the
520		-	16.23medical cannabis manufacturer is transporting medical cannabis to either a certified
521		-	16.24laboratory for the purpose of testing or a facility for the purpose of disposal. If the medical
522		-	16.25cannabis manufacturer is transporting medical cannabis for any other purpose or destination,
523		-	16.26the transport motor vehicle must be staffed with a minimum of two employees as required
524		-	16.27by rules adopted by the commissioner office.
525		-	16.28 (b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only
526		-	16.29transporting hemp for any purpose may staff the transport motor vehicle with only one
527		-	16.30employee.
528		-	16Sec. 18.
529		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 17.1 (c) A medical cannabis manufacturer may contract with a third party for armored car
530		-	17.2services for deliveries of medical cannabis from its production facility to distribution
531		-	17.3facilities. A medical cannabis manufacturer that contracts for armored car services remains
532		-	17.4responsible for the transportation manifest and inventory tracking requirements in rules
533		-	17.5adopted by the commissioner office.
534		-	17.6 (d) Department of Health Office staff may transport medical cannabis for the purposes
535		-	17.7of delivering medical cannabis and other samples to a laboratory for testing under rules
536		-	17.8adopted by the commissioner office and in cases of special investigations when the
537		-	17.9commissioner office has determined there is a potential threat to public health. The transport
538		-	17.10motor vehicle must be staffed with a minimum of two Department of Health office
539		-	17.11employees. The employees must carry with them their Department of Health office
540		-	17.12identification card and a transport manifest.
541		-	17.13Sec. 19. Minnesota Statutes 2024, section 152.29, subdivision 4, is amended to read:
542		-	17.14 Subd. 4.Report.(a) Each manufacturer shall report to the commissioner office on a
543		-	17.15monthly basis the following information on each individual patient for the month prior to
544		-	17.16the report:
545		-	17.17 (1) the amount and dosages of medical cannabis distributed;
546		-	17.18 (2) the chemical composition of the medical cannabis; and
547		-	17.19 (3) the tracking number assigned to any medical cannabis distributed.
548		-	17.20 (b) For transactions involving Tribal medical cannabis program patients, each
549		-	17.21manufacturer shall report to the commissioner office on a weekly basis the following
550		-	17.22information on each individual Tribal medical cannabis program patient for the week prior
551		-	17.23to the report:
552		-	17.24 (1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis
553		-	17.25program patient is enrolled;
554		-	17.26 (2) the amount and dosages of medical cannabis distributed;
555		-	17.27 (3) the chemical composition of the medical cannabis distributed; and
556		-	17.28 (4) the tracking number assigned to the medical cannabis distributed.
557		-	17Sec. 19.
558		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 18.1 Sec. 20. Minnesota Statutes 2024, section 152.31, is amended to read:
559		-	18.2 152.31 DATA PRACTICES.
560		-	18.3 (a) Government data in patient files maintained by the commissioner office and the
561		-	18.4health care practitioner, and data submitted to or by a medical cannabis manufacturer, are
562		-	18.5private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data,
563		-	18.6as defined in section 13.02, subdivision 9, but may be used for purposes of complying with
564		-	18.7chapter 13 and complying with a request from the legislative auditor or the state auditor in
565		-	18.8the performance of official duties. The provisions of section 13.05, subdivision 11, apply
566		-	18.9to a registration agreement entered between the commissioner office and a medical cannabis
567		-	18.10manufacturer under section 152.25.
568		-	18.11 (b) Not public data maintained by the commissioner office may not be used for any
569		-	18.12purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked
570		-	18.13in any manner with any other list, dataset, or database.
571		-	18.14 (c) The commissioner office may execute data sharing arrangements with the
572		-	18.15commissioner of agriculture to verify licensing, inspection, and compliance information
573		-	18.16related to hemp growers and hemp processors under chapter 18K.
574		-	18.17Sec. 21. Minnesota Statutes 2024, section 152.32, subdivision 2, is amended to read:
575		-	18.18 Subd. 2.Criminal and civil protections.(a) Subject to section 152.23, the following
576		-	18.19are not violations under this chapter:
577		-	18.20 (1) use or possession of medical cannabis or medical cannabis products by a patient
578		-	18.21enrolled in the registry program; possession by a registered designated caregiver or the
579		-	18.22parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed
580		-	18.23on the registry verification; or use or possession of medical cannabis or medical cannabis
581		-	18.24products by a Tribal medical cannabis program patient;
582		-	18.25 (2) possession, dosage determination, or sale of medical cannabis or medical cannabis
583		-	18.26products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical
584		-	18.27cannabis program manufacturer, employees of a Tribal medical cannabis program
585		-	18.28manufacturer, a laboratory conducting testing on medical cannabis, or employees of the
586		-	18.29laboratory; and
587		-	18.30 (3) possession of medical cannabis or medical cannabis products by any person while
588		-	18.31carrying out the duties required under sections 152.22 to 152.37.
589		-	18Sec. 21.
590		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 19.1 (b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and
591		-	19.2associated property is not subject to forfeiture under sections 609.531 to 609.5316.
592		-	19.3 (c) The commissioner office, members of a Tribal medical cannabis board, the
593		-	19.4commissioner's office's or Tribal medical cannabis board's staff, the commissioner's office's
594		-	19.5or Tribal medical cannabis board's agents or contractors, and any health care practitioner
595		-	19.6are not subject to any civil or disciplinary penalties by the Board of Medical Practice, the
596		-	19.7Board of Nursing, or by any business, occupational, or professional licensing board or entity,
597		-	19.8solely for participation in the registry program under sections 152.22 to 152.37 or in a Tribal
598		-	19.9medical cannabis program. A pharmacist licensed under chapter 151 is not subject to any
599		-	19.10civil or disciplinary penalties by the Board of Pharmacy when acting in accordance with
600		-	19.11the provisions of sections 152.22 to 152.37. Nothing in this section affects a professional
601		-	19.12licensing board from taking action in response to violations of any other section of law.
602		-	19.13 (d) Notwithstanding any law to the contrary, the commissioner office, the governor of
603		-	19.14Minnesota, or an employee of any state agency may not be held civilly or criminally liable
604		-	19.15for any injury, loss of property, personal injury, or death caused by any act or omission
605		-	19.16while acting within the scope of office or employment under sections 152.22 to 152.37.
606		-	19.17 (e) Federal, state, and local law enforcement authorities are prohibited from accessing
607		-	19.18the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid
608		-	19.19search warrant.
609		-	19.20 (f) Notwithstanding any law to the contrary, neither the commissioner office nor a public
610		-	19.21employee may release data or information about an individual contained in any report,
611		-	19.22document, or registry created under sections 152.22 to 152.37 or any information obtained
612		-	19.23about a patient participating in the program, except as provided in sections 152.22 to 152.37.
613		-	19.24 (g) No information contained in a report, document, or registry or obtained from a patient
614		-	19.25under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be
615		-	19.26admitted as evidence in a criminal proceeding unless independently obtained or in connection
616		-	19.27with a proceeding involving a violation of sections 152.22 to 152.37.
617		-	19.28 (h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty
618		-	19.29of a gross misdemeanor.
619		-	19.30 (i) An attorney may not be subject to disciplinary action by the Minnesota Supreme
620		-	19.31Court, a Tribal court, or the professional responsibility board for providing legal assistance
621		-	19.32to prospective or registered manufacturers or others related to activity that is no longer
622		-	19.33subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for
623		-	19Sec. 21.
624		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 20.1providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis
625		-	20.2program manufacturer.
626		-	20.3 (j) The following do not constitute probable cause or reasonable suspicion, and shall not
627		-	20.4be used to support a search of the person or property of the person possessing or applying
628		-	20.5for the registry verification or equivalent, or otherwise subject the person or property of the
629		-	20.6person to inspection by any governmental agency:
630		-	20.7 (1) possession of a registry verification or application for enrollment in the registry
631		-	20.8program by a person entitled to possess a registry verification or apply for enrollment in
632		-	20.9the registry program; or
633		-	20.10 (2) possession of a verification or equivalent issued by a Tribal medical cannabis program
634		-	20.11or application for enrollment in a Tribal medical cannabis program by a person entitled to
635		-	20.12possess such a verification or application.
636		-	20.13Sec. 22. Minnesota Statutes 2024, section 152.33, subdivision 1a, is amended to read:
637		-	20.14 Subd. 1a.Intentional diversion outside the state; penalties.(a) In addition to any other
638		-	20.15applicable penalty in law, the commissioner office may levy a fine of $250,000 against a
639		-	20.16manufacturer and may immediately initiate proceedings to revoke the manufacturer's
640		-	20.17registration, using the procedure in section 152.25, if:
641		-	20.18 (1) an officer, director, or controlling person of the manufacturer pleads or is found
642		-	20.19guilty under subdivision 1 of intentionally transferring medical cannabis, while the person
643		-	20.20was an officer, director, or controlling person of the manufacturer, to a person other than
644		-	20.21allowed by law; and
645		-	20.22 (2) in intentionally transferring medical cannabis to a person other than allowed by law,
646		-	20.23the officer, director, or controlling person transported or directed the transport of medical
647		-	20.24cannabis outside of Minnesota.
648		-	20.25 (b) All fines collected under this subdivision shall be deposited in the state government
649		-	20.26special revenue fund.
650		-	20.27Sec. 23. Minnesota Statutes 2024, section 152.33, subdivision 4, is amended to read:
651		-	20.28 Subd. 4.Submission of false records; criminal penalty.A person who knowingly
652		-	20.29submits false records or documentation required by the commissioner office to register as
653		-	20.30a manufacturer of medical cannabis under sections 152.22 to 152.37 is guilty of a felony
654		-	20.31and may be sentenced to imprisonment for not more than two years or by payment of a fine
655		-	20.32of not more than $3,000, or both.
656		-	20Sec. 23.
657		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 21.1 Sec. 24. Minnesota Statutes 2024, section 152.35, is amended to read:
658		-	21.2 152.35 FEES; DEPOSIT OF REVENUE.
659		-	21.3 (a) The commissioner office shall collect an application fee of $20,000 from each entity
660		-	21.4submitting an application for registration as a medical cannabis manufacturer. Revenue
661		-	21.5from the fee shall be deposited in the state treasury and credited to the state government
662		-	21.6special revenue fund.
663		-	21.7 (b) The commissioner office shall establish and collect an annual fee from a medical
664		-	21.8cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in
665		-	21.9that year. Revenue from the fee amount shall be deposited in the state treasury and credited
666		-	21.10to the state government special revenue fund.
667		-	21.11 (c) A medical cannabis manufacturer may charge patients enrolled in the registry program
668		-	21.12a reasonable fee for costs associated with the operations of the manufacturer. The
669		-	21.13manufacturer may establish a sliding scale of patient fees based upon a patient's household
670		-	21.14income and may accept private donations to reduce patient fees.
671		-	21.15Sec. 25. Minnesota Statutes 2024, section 152.37, is amended to read:
672		-	21.16 152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.
673		-	21.17 Subdivision 1.Financial records.A medical cannabis manufacturer shall maintain
674		-	21.18detailed financial records in a manner and format approved by the commissioner office,
675		-	21.19and shall keep all records updated and accessible to the commissioner office when requested.
676		-	21.20 Subd. 2.Certified annual audit.A medical cannabis manufacturer shall submit the
677		-	21.21results of an annual certified financial audit to the commissioner office no later than May
678		-	21.221 of each year for the calendar year beginning January 2015. The annual audit shall be
679		-	21.23conducted by an independent certified public accountant and the costs of the audit are the
680		-	21.24responsibility of the medical cannabis manufacturer. Results of the audit shall be provided
681		-	21.25to the medical cannabis manufacturer and the commissioner office. The commissioner office
682		-	21.26may also require another audit of the medical cannabis manufacturer by a certified public
683		-	21.27accountant chosen by the commissioner office with the costs of the audit paid by the medical
684		-	21.28cannabis manufacturer.
685		-	21.29 Subd. 3.Power to examine.(a) The commissioner office or designee may examine the
686		-	21.30business affairs and conditions of any medical cannabis manufacturer, including but not
687		-	21.31limited to a review of the financing, budgets, revenues, sales, and pricing.
688		-	21Sec. 25.
689		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 22.1 (b) An examination may cover the medical cannabis manufacturer's business affairs,
690		-	22.2practices, and conditions including but not limited to a review of the financing, budgets,
691		-	22.3revenues, sales, and pricing. The commissioner office shall determine the nature and scope
692		-	22.4of each examination and in doing so shall take into account all available relevant factors
693		-	22.5concerning the financial and business affairs, practices, and conditions of the examinee.
694		-	22.6The costs incurred by the department in conducting an examination shall be paid for by the
695		-	22.7medical cannabis manufacturer.
696		-	22.8 (c) When making an examination under this section, the commissioner office may retain
697		-	22.9attorneys, appraisers, independent economists, independent certified public accountants, or
698		-	22.10other professionals and specialists as designees. A certified public accountant retained by
699		-	22.11the commissioner office may not be the same certified public accountant providing the
700		-	22.12certified annual audit in subdivision 2.
701		-	22.13 (d) The commissioner office shall make a report of an examination conducted under this
702		-	22.14section and provide a copy to the medical cannabis manufacturer. The commissioner office
703		-	22.15shall then post a copy of the report on the department's website. All working papers, recorded
704		-	22.16information, documents, and copies produced by, obtained by, or disclosed to the
705		-	22.17commissioner office or any other person in the course of an examination, other than the
706		-	22.18information contained in any commissioner office official report, made under this section
707		-	22.19are private data on individuals or nonpublic data, as defined in section 13.02.
708		-	22.20Sec. 26. Minnesota Statutes 2024, section 342.01, subdivision 9, is amended to read:
709		-	22.21 Subd. 9.Bona fide labor organization."Bona fide labor organization" means a labor
710		-	22.22union that represents or is actively seeking to represent cannabis workers. of:
711		-	22.23 (1) a cannabis business; or
712		-	22.24 (2) a lower-potency hemp edible manufacturer.
713		-	22.25Sec. 27. Minnesota Statutes 2024, section 342.01, subdivision 47, is amended to read:
714		-	22.26 Subd. 47.Labor peace agreement."Labor peace agreement" means an agreement
715		-	22.27between a cannabis business and a bona fide labor organization or an agreement between
716		-	22.28a lower-potency hemp edible manufacturer and a bona fide labor organization that protects
717		-	22.29the state's interests by, at minimum, prohibiting the labor organization from engaging in
718		-	22.30picketing, work stoppages, or boycotts against the cannabis business or lower-potency hemp
719		-	22.31edible manufacturer.
720		-	22Sec. 27.
721		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 23.1 Sec. 28. Minnesota Statutes 2024, section 342.01, subdivision 50, is amended to read:
722		-	23.2 Subd. 50.Lower-potency hemp edible.(a) "Lower-potency hemp edible" means any
723		-	23.3product that:
724		-	23.4 (1) is intended to be eaten or consumed as a beverage by humans;
725		-	23.5 (2) contains hemp concentrate or an artificially derived cannabinoid, in combination
726		-	23.6with food ingredients;
727		-	23.7 (3) is not a drug;
728		-	23.8 (4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
729		-	23.9 (5) is a type of product approved for sale by the office or is substantially similar to a
730		-	23.10product approved by the office, including but not limited to products that resemble
731		-	23.11nonalcoholic beverages, candy, and baked goods; and
732		-	23.12 (6) meets either of the requirements in paragraph (b).
733		-	23.13 (b) A lower-potency hemp edible includes:
734		-	23.14 (1) a product that:
735		-	23.15 (i) consists of servings that contain no more than five milligrams of delta-9
736		-	23.16tetrahydrocannabinol; no more than 25 milligrams of cannabidiol, cannabigerol, cannabinol,
737		-	23.17or cannabichromene; any other cannabinoid authorized by the office; or any combination
738		-	23.18of those cannabinoids that does not exceed the identified amounts, except that a
739		-	23.19lower-potency hemp edible that is intended to be consumed as a beverage may contain no
740		-	23.20more than ten milligrams of delta-9 tetrahydrocannabinol in a single-serving container;
741		-	23.21 (ii) does not contain more than a combined total of 0.5 milligrams of all other
742		-	23.22cannabinoids per serving; and
743		-	23.23 (iii) does not contain an artificially derived cannabinoid other than delta-9
744		-	23.24tetrahydrocannabinol, except that a product may include artificially derived cannabinoids
745		-	23.25created during the process of creating the delta-9 tetrahydrocannabinol that is added to the
746		-	23.26product, if no artificially derived cannabinoid is added to the ingredient containing delta-9
747		-	23.27tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially
748		-	23.28derived cannabinoids is no less than 20 to one; or
749		-	23.29 (2) a product that:
750		-	23.30 (i) contains hemp concentrate processed or refined without increasing the percentage of
751		-	23.31targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp
752		-	23Sec. 28.
753		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 24.1plant or hemp plant parts beyond the variability generally recognized for the method used
754		-	24.2for processing or refining or by an amount needed to reduce the total THC in the hemp
755		-	24.3concentrate; and
756		-	24.4 (ii) consists of servings that contain no more than five milligrams of total THC.
757		-	24.5 Sec. 29. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
758		-	24.6read:
759		-	24.7 Subd. 54a.Medical cannabis paraphernalia."Medical cannabis paraphernalia" means
760		-	24.8a delivery device, related supply, or educational material used by a patient enrolled in the
761		-	24.9registry program to administer medical cannabis and medical cannabinoid products.
762		-	24.10Sec. 30. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
763		-	24.11read:
764		-	24.12 Subd. 69c.Tribal medical cannabis board."Tribal medical cannabis board" means an
765		-	24.13agency established by a federally recognized Tribal government and authorized by the
766		-	24.14Tribe's governing body to provide regulatory oversight and monitor compliance with a
767		-	24.15Tribal medical cannabis program and applicable regulations.
768		-	24.16Sec. 31. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
769		-	24.17read:
770		-	24.18 Subd. 69d.Tribal medical cannabis program."Tribal medical cannabis program"
771		-	24.19means a program established by a federally recognized Tribal government within the
772		-	24.20boundaries of Minnesota that involves the commercial production, processing, sale or
773		-	24.21distribution, and possession of medical cannabis and medical cannabis products.
774		-	24.22Sec. 32. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
775		-	24.23read:
776		-	24.24 Subd. 69e.Tribal medical cannabis program patient."Tribal medical cannabis program
777		-	24.25patient" means a person who possesses a valid registration verification card or equivalent
778		-	24.26document that is issued under the laws or regulations of a Tribal Nation within the boundaries
779		-	24.27of Minnesota. A valid registration verification card must verify that the card holder is
780		-	24.28enrolled in or authorized to participate in a Tribal medical cannabis program.
781		-	24Sec. 32.
782		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 25.1 Sec. 33. Minnesota Statutes 2024, section 342.01, subdivision 71, is amended to read:
783		-	25.2 Subd. 71.Visiting patient."Visiting patient" means an individual who is not a Minnesota
784		-	25.3resident and who possesses a valid registration verification card or its equivalent that is
785		-	25.4issued under the laws or regulations of another state, district, commonwealth, or territory
786		-	25.5of the United States verifying that the individual is enrolled in or authorized to participate
787		-	25.6in that jurisdiction's medical cannabis or medical marijuana program or in a Tribal medical
788		-	25.7cannabis program.
789		-	25.8 Sec. 34. Minnesota Statutes 2024, section 342.02, subdivision 3, is amended to read:
790		-	25.9 Subd. 3.Medical cannabis program.(a) The powers and duties of the Department of
791		-	25.10Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
792		-	25.11152.22 to 152.37, are transferred to the Office of Cannabis Management under section
793		-	25.1215.039.
794		-	25.13 (b) The following protections shall apply to employees who are transferred from the
795		-	25.14Department of Health to the Office of Cannabis Management:
796		-	25.15 (1) the employment status and job classification of a transferred employee shall not be
797		-	25.16altered as a result of the transfer;
798		-	25.17 (2) transferred employees who were represented by an exclusive representative prior to
799		-	25.18the transfer shall continue to be represented by the same exclusive representative after the
800		-	25.19transfer;
801		-	25.20 (3) the applicable collective bargaining agreements with exclusive representatives shall
802		-	25.21continue in full force and effect for such transferred employees after the transfer;
803		-	25.22 (4) the state must meet and negotiate with the exclusive representatives of the transferred
804		-	25.23employees about any proposed changes affecting or relating to the transferred employees'
805		-	25.24terms and conditions of employment to the extent such changes are not addressed in the
806		-	25.25applicable collective bargaining agreement; and
807		-	25.26 (5) for an employee in a temporary unclassified position transferred to the Office of
808		-	25.27Cannabis Management, the total length of time that the employee has served in the
809		-	25.28appointment shall include all time served in the appointment and the transferring agency
810		-	25.29and the time served in the appointment at the Office of Cannabis Management. An employee
811		-	25.30in a temporary unclassified position who was hired by a transferring agency through an
812		-	25.31open competitive selection process in accordance with a policy enacted by Minnesota
813		-	25.32Management and Budget shall be considered to have been hired through such process after
814		-	25.33the transfer.
815		-	25Sec. 34.
816		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 26.1 (c) This subdivision is effective July 1, 2024.
817		-	26.2 Sec. 35. Minnesota Statutes 2024, section 342.09, subdivision 2, is amended to read:
818		-	26.3 Subd. 2.Home cultivation of cannabis for personal adult use.(a) Up to eight cannabis
819		-	26.4plants, with no more than four being mature, flowering plants may be grown at a single
820		-	26.5residence, including the curtilage or yard, without a license to cultivate cannabis issued
821		-	26.6under this chapter provided that cultivation takes place at the primary residence of an
822		-	26.7individual 21 years of age or older and in an enclosed, locked space that is not open to public
823		-	26.8view.
824		-	26.9 (b) Pursuant to section 342.52, subdivision 9, paragraph (d), a registered designated
825		-	26.10caregiver may cultivate up to eight cannabis plants for not more than one patient household.
826		-	26.11In addition to eight cannabis plants for one patient household, a registered designated
827		-	26.12caregiver may cultivate up to eight cannabis plants for the caregiver's personal adult use of
828		-	26.13cannabis. Of the 16 or fewer total cannabis plants being grown in the registered caregiver's
829		-	26.14residence, no more than eight may be mature, flowering plants.
830		-	26.15Sec. 36. Minnesota Statutes 2024, section 342.12, is amended to read:
831		-	26.16 342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
832		-	26.17 (a) Licenses issued under this chapter that are available to all applicants pursuant to
833		-	26.18section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior
834		-	26.19written approval of the office unless the license holder has not received a final site inspection
835		-	26.20or the license holder is a social equity applicant.
836		-	26.21 (b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision
837		-	26.221b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another
838		-	26.23social equity applicant for three years after the date on which the office issues the license.
839		-	26.24Three years after the date of issuance, a license holder may transfer a license to any entity.
840		-	26.25Transfer of a license that was issued as a social equity license must be reviewed by the
841		-	26.26Division of Social Equity and is subject to the prior written approval of the office.
842		-	26.27 (c) Preliminary license preapproval approval issued pursuant to section 342.125 342.14,
843		-	26.28subdivision 5, may not be transferred.
844		-	26.29 (d) A new license must be obtained when:
845		-	26.30 (1) the form of the licensee's legal business structure converts or changes to a different
846		-	26.31type of legal business structure; or
847		-	26Sec. 36.
848		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 27.1 (2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,
849		-	27.2or receivership proceedings; merges with another legal organization; or assigns all or
850		-	27.3substantially all of its assets for the benefit of creditors.
851		-	27.4 (e) Licenses must be renewed annually.
852		-	27.5 (f) License holders may petition the office to adjust the tier of a license issued within a
853		-	27.6license category if the license holder meets all applicable requirements.
854		-	27.7 (g) The office by rule may permit the relocation of a licensed cannabis business; permit
855		-	27.8the relocation of an approved operational location, including a cultivation, manufacturing,
856		-	27.9processing, or retail location; adopt requirements for the submission of a license relocation
857		-	27.10application; establish standards for the approval of a relocation application; and charge a
858		-	27.11fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed
859		-	27.12premises pursuant to this paragraph does not extend or otherwise modify the license term
860		-	27.13of the license subject to relocation.
861		-	27.14Sec. 37. Minnesota Statutes 2024, section 342.14, subdivision 1, is amended to read:
862		-	27.15 Subdivision 1.Application; contents.(a) The office shall establish procedures for the
863		-	27.16processing of cannabis licenses issued under this chapter. At a minimum, any application
864		-	27.17to obtain or renew a cannabis license shall include the following information, if applicable:
865		-	27.18 (1) the name, address, and date of birth of the applicant;
866		-	27.19 (2) the disclosure of ownership and control required under paragraph (b);
867		-	27.20 (3) the disclosure of whether the applicant or, if the applicant is a business, any officer,
868		-	27.21director, manager, and general partner of the business has ever filed for bankruptcy;
869		-	27.22 (4) the address and legal property description of the business, if applicable, except an
870		-	27.23applicant is not required to secure a physical premises for the business at the time of
871		-	27.24application;
872		-	27.25 (5) a general description of the location or locations that the applicant plans to operate,
873		-	27.26including the planned square feet of space for cultivation, wholesaling, and retailing, as
874		-	27.27applicable;
875		-	27.28 (6) a copy of the security plan, including security monitoring, security equipment, and
876		-	27.29facility maps if applicable, except an applicant is not required to secure a physical premises
877		-	27.30for the business at the time of application;
878		-	27.31 (7) proof of trade name registration;
879		-	27Sec. 37.
880		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 28.1 (8) a copy of the applicant's business plan showing the expected size of the business;
881		-	28.2anticipated growth; the methods of record keeping; the knowledge and experience of the
882		-	28.3applicant and any officer, director, manager, and general partner of the business; the
883		-	28.4environmental plan; and other relevant financial and operational components;
884		-	28.5 (9) standard operating procedures for:
885		-	28.6 (i) quality assurance;
886		-	28.7 (ii) inventory control, storage, and diversion prevention; and
887		-	28.8 (iii) accounting and tax compliance;
888		-	28.9 (10) an attestation signed by a bona fide labor organization stating that the applicant has
889		-	28.10entered into a labor peace agreement;
890		-	28.11 (11) a description of any training and education that the applicant will provide to
891		-	28.12employees of the business;
892		-	28.13 (12) a disclosure of any violation of a license agreement or a federal, state, or local law
893		-	28.14or regulation committed by the applicant or any true party of interest in the applicant's
894		-	28.15business that is relevant to business and working conditions;
895		-	28.16 (13) certification that the applicant will comply with the requirements of this chapter;
896		-	28.17 (14) identification of one or more controlling persons or managerial employees as agents
897		-	28.18who shall be responsible for dealing with the office on all matters;
898		-	28.19 (15) a statement that the applicant agrees to respond to the office's supplemental requests
899		-	28.20for information; and
900		-	28.21 (16) a release of information for the applicant and every true party of interest in the
901		-	28.22applicant's business license for the office to perform the background checks required under
902		-	28.23section 342.15.;
903		-	28.24 (17) proof that the applicant is a social equity applicant; and
904		-	28.25 (18) an attestation that the applicant's business policies governing business operations
905		-	28.26comply with this chapter.
906		-	28.27 (b) An applicant must file and update as necessary a disclosure of ownership and control
907		-	28.28identifying any true party of interest as defined in section 342.185, subdivision 1, paragraph
908		-	28.29(g). The office shall establish the contents of the disclosure. Except as provided in paragraph
909		-	28.30(f) (d), the disclosure shall, at a minimum, include the following:
910		-	28Sec. 37.
911		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 29.1 (1) the management structure, ownership, and control of the applicant or license holder,
912		-	29.2including the name of each cooperative member, officer, director, manager, general partner,
913		-	29.3or business entity; the office or position held by each person; each person's percentage
914		-	29.4ownership interest, if any; and, if the business has a parent company, the name of each
915		-	29.5owner, board member, and officer of the parent company and the owner's, board member's,
916		-	29.6or officer's percentage ownership interest in the parent company and the cannabis business;
917		-	29.7 (2) a statement from the applicant and, if the applicant is a business, from every officer,
918		-	29.8director, manager, and general partner of the business, indicating whether that person has
919		-	29.9previously held, or currently holds, an ownership interest in a cannabis business in Minnesota,
920		-	29.10any other state or territory of the United States, or any other country;
921		-	29.11 (3) if the applicant is a corporation, copies of the applicant's articles of incorporation
922		-	29.12and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
923		-	29.13 (4) copies of any partnership agreement, operating agreement, or shareholder agreement;
924		-	29.14 (5) copies of any promissory notes, security instruments, or other similar agreements;
925		-	29.15 (6) an explanation detailing the funding sources used to finance the business;
926		-	29.16 (7) a list of operating and investment accounts for the business, including any applicable
927		-	29.17financial institution and account number; and
928		-	29.18 (8) a list of each outstanding loan and financial obligation obtained for use in the business,
929		-	29.19including the loan amount, loan terms, and name and address of the creditor.
930		-	29.20 (c) An application may include:
931		-	29.21 (1) proof that the applicant is a social equity applicant;
932		-	29.22 (2) a description of the training and education that will be provided to any employee;
933		-	29.23or
934		-	29.24 (3) a copy of business policies governing operations to ensure compliance with this
935		-	29.25chapter.
936		-	29.26 (d) (c) Commitments made by an applicant in its application, including but not limited
937		-	29.27to the maintenance of a labor peace agreement, shall be an ongoing material condition of
938		-	29.28maintaining and renewing the license.
939		-	29.29 (e) An application on behalf of a corporation or association shall be signed by at least
940		-	29.30two officers or managing agents of that entity.
941		-	29Sec. 37.
942		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 30.1 (f) (d) The office may establish exceptions to the disclosures required under paragraph
943		-	30.2(b) for members of a cooperative who hold less than a five percent ownership interest in
944		-	30.3the cooperative.
945		-	30.4 Sec. 38. Minnesota Statutes 2024, section 342.14, subdivision 3, is amended to read:
946		-	30.5 Subd. 3.Review.(a) After an applicant submits an application that contains all required
947		-	30.6information and pays the applicable licensing application fee, the office must review the
948		-	30.7application.
949		-	30.8 (b) The office may deny an application if:
950		-	30.9 (1) the application is incomplete;
951		-	30.10 (2) the application contains a materially false statement about the applicant or omits
952		-	30.11information required under subdivision 1;
953		-	30.12 (3) the applicant does not meet the qualifications under section 342.16;
954		-	30.13 (4) the applicant is prohibited from holding the license under section 342.18, subdivision
955		-	30.142;
956		-	30.15 (5) the application does not meet the minimum requirements under section 342.18,
957		-	30.16subdivision 3;
958		-	30.17 (6) the applicant fails to pay the applicable application fee;
959		-	30.18 (7) the application was not submitted by the application deadline;
960		-	30.19 (8) the applicant submitted more than one application for a license type; or
961		-	30.20 (9) the office determines that the applicant would be prohibited from holding a license
962		-	30.21for any other reason.
963		-	30.22 (c) If the office denies an application, the office must notify the applicant of the denial
964		-	30.23and the basis for the denial.
965		-	30.24 (d) The office may request additional information from any applicant if the office
966		-	30.25determines that the information is necessary to review or process the application. If the
967		-	30.26applicant does not provide the additional requested information within 14 calendar days of
968		-	30.27the office's request for information, the office may deny the application.
969		-	30.28 (e) An applicant whose application is not denied under this subdivision is a qualified
970		-	30.29applicant.
971		-	30Sec. 38.
972		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 31.1 Sec. 39. Minnesota Statutes 2024, section 342.14, subdivision 6, is amended to read:
973		-	31.2 Subd. 6.Completed application; final authorization; issuance of license.(a) Within
974		-	31.318 months of receiving notice of preliminary license approval, an applicant must provide:
975		-	31.4 (1) the address and legal property description of the location where the business will
976		-	31.5operate;
977		-	31.6 (2) the name of the local unit of government where the business will be located; and
978		-	31.7 (3) if applicable, an updated description of the location where the business will operate,
979		-	31.8an updated security plan, and any other additional information required by the office.
980		-	31.9 (b) Upon receipt of the information required under paragraph (a) from an applicant that
981		-	31.10has received preliminary license approval, the office must:
982		-	31.11 (1) forward a copy of the application to the local unit of government in which the business
983		-	31.12operates or intends to operate with a form for certification as to whether a proposed cannabis
984		-	31.13business complies with local zoning ordinances and, if applicable, whether the proposed
985		-	31.14business complies with the state fire code and building code;
986		-	31.15 (2) schedule a site inspection; and
987		-	31.16 (3) require the applicant to pay the applicable license fee.
988		-	31.17 (c) The office may deny final authorization if:
989		-	31.18 (1) an applicant fails to submit any required information;
990		-	31.19 (2) the applicant submits a materially false statement about the applicant or fails to
991		-	31.20provide any required information;
992		-	31.21 (3) the office confirms that the cannabis business for which the office granted a
993		-	31.22preliminary license preapproval approval does not meet local zoning and land use laws;
994		-	31.23 (4) the applicant fails to pay the applicable license fee; or
995		-	31.24 (5) the office determines that the applicant is disqualified from holding the license or
996		-	31.25would operate in violation of the provisions of this chapter.
997		-	31.26 (d) Within 90 days of receiving the information required under paragraph (a) and the
998		-	31.27results of any required background check, the office shall grant final authorization and issue
999		-	31.28the appropriate license or send the applicant a notice of rejection setting forth specific
1000		-	31.29reasons that the office did not approve the application.
1001		-	31Sec. 39.
1002		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 32.1 Sec. 40. Minnesota Statutes 2024, section 342.151, subdivision 2, is amended to read:
1003		-	32.2 Subd. 2.Criminal history check.A license holder cannabis business may employ or
1004		-	32.3contract with as many unlicensed individuals as may be necessary, provided that the license
1005		-	32.4holder cannabis business is at all times accountable for the good conduct of every individual
1006		-	32.5employed by or contracted with the license holder cannabis business. Before hiring an
1007		-	32.6individual as a cannabis worker, the license holder cannabis business must submit to the
1008		-	32.7Bureau of Criminal Apprehension the individual's full set of fingerprints and written consent
1009		-	32.8for the bureau to conduct a state and national criminal history check. The bureau may
1010		-	32.9exchange an individual's fingerprints with the Federal Bureau of Investigation. The Bureau
1011		-	32.10of Criminal Apprehension must determine whether the individual is qualified to be employed
1012		-	32.11as a cannabis worker and must notify the license holder cannabis business of the bureau's
1013		-	32.12determination. The license holder cannabis business must not employ an individual who is
1014		-	32.13disqualified from being employed as a cannabis worker.
1015		-	32.14Sec. 41. Minnesota Statutes 2024, section 342.151, subdivision 3, is amended to read:
1016		-	32.15 Subd. 3.Disqualification.(a) A license holder cannabis business must not employ an
1017		-	32.16individual as a cannabis worker if the individual has been convicted of any of the following
1018		-	32.17crimes that would constitute a felony:
1019		-	32.18 (1) human trafficking;
1020		-	32.19 (2) noncannabis controlled substance crimes in the first or second degree;
1021		-	32.20 (3) labor trafficking;
1022		-	32.21 (4) fraud;
1023		-	32.22 (5) embezzlement;
1024		-	32.23 (6) extortion;
1025		-	32.24 (7) money laundering; or
1026		-	32.25 (8) insider trading;
1027		-	32.26if committed in this state or any other jurisdiction for which a full pardon or similar relief
1028		-	32.27has not been granted.
1029		-	32.28 (b) A license holder cannabis business must not employ an individual as a cannabis
1030		-	32.29worker if the individual made any false statement in an application for employment.
1031		-	32Sec. 41.
1032		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 33.1 Sec. 42. Minnesota Statutes 2024, section 342.22, subdivision 3, is amended to read:
1033		-	33.2 Subd. 3.Issuance of registration.(a) A local unit of government shall issue a retail
1034		-	33.3registration to a cannabis microbusiness with a retail operations endorsement, cannabis
1035		-	33.4mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis
1036		-	33.5combination business operating a retail location, or lower-potency hemp edible retailer that:
1037		-	33.6 (1) has a valid license or preliminary license preapproval approval issued by the office;
1038		-	33.7 (2) has paid the registration fee or renewal fee pursuant to subdivision 2;
1039		-	33.8 (3) is found to be in compliance with the requirements of this chapter at any preliminary
1040		-	33.9compliance check that the local unit of government performs; and
1041		-	33.10 (4) if applicable, is current on all property taxes and assessments at the location where
1042		-	33.11the retail establishment is located.
1043		-	33.12 (b) Before issuing a retail registration, the local unit of government may conduct a
1044		-	33.13preliminary compliance check to ensure that the cannabis business or hemp business is in
1045		-	33.14compliance with any applicable local ordinance established pursuant to section 342.13.
1046		-	33.15 (c) A local unit of government shall renew the retail registration of a cannabis business
1047		-	33.16or hemp business when the office renews the license of the cannabis business or hemp
1048		-	33.17business.
1049		-	33.18 (d) A retail registration issued under this section may not be transferred.
1050		-	33.19Sec. 43. Minnesota Statutes 2024, section 342.28, subdivision 1, is amended to read:
1051		-	33.20 Subdivision 1.Authorized actions.A cannabis microbusiness license, consistent with
1052		-	33.21the specific license endorsement or endorsements, entitles the license holder to perform any
1053		-	33.22or all of the following within the limits established by this section:
1054		-	33.23 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
1055		-	33.24cannabis flower from a mature plant;
1056		-	33.25 (2) make cannabis concentrate;
1057		-	33.26 (3) make hemp concentrate, including hemp concentrate with a delta-9
1058		-	33.27tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
1059		-	33.28 (4) manufacture artificially derived cannabinoids;
1060		-	33.29 (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and
1061		-	33.30hemp-derived consumer products for public consumption;
1062		-	33Sec. 43.
1063		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 34.1 (6) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis
1064		-	34.2products, lower-potency hemp edibles, and hemp-derived consumer products from another
1065		-	34.3cannabis microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis
1066		-	34.4manufacturer, or a cannabis wholesaler, or a lower-potency hemp edible manufacturer;
1067		-	34.5 (7) purchase hemp plant parts and propagules from an industrial hemp grower licensed
1068		-	34.6under chapter 18K;
1069		-	34.7 (8) purchase hemp concentrate from an industrial hemp processor licensed under chapter
1070		-	34.818K;
1071		-	34.9 (9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
1072		-	34.10from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer,
1073		-	34.11or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency
1074		-	34.12hemp edibles, or hemp-derived consumer products;
1075		-	34.13 (10) package and label adult-use cannabis flower, adult-use cannabis products,
1076		-	34.14lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
1077		-	34.15 (11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
1078		-	34.16cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
1079		-	34.17other products authorized by law to other cannabis businesses and to customers;
1080		-	34.18 (12) operate an establishment that permits on-site consumption of edible cannabis
1081		-	34.19products and lower-potency hemp edibles; and
1082		-	34.20 (13) perform other actions approved by the office.
1083		-	34.21Sec. 44. Minnesota Statutes 2024, section 342.28, subdivision 8, is amended to read:
1084		-	34.22 Subd. 8.Production of customer consumer products endorsement.A cannabis
1085		-	34.23microbusiness that manufactures edible cannabis products, lower-potency hemp products,
1086		-	34.24or hemp-derived consumer products must comply with the requirements in section 342.26,
1087		-	34.25subdivisions 2 and 4.
1088		-	34.26Sec. 45. Minnesota Statutes 2024, section 342.29, subdivision 1, is amended to read:
1089		-	34.27 Subdivision 1.Authorized actions.A cannabis mezzobusiness license, consistent with
1090		-	34.28the specific license endorsement or endorsements, entitles the license holder to perform any
1091		-	34.29or all of the following within the limits established by this section:
1092		-	34Sec. 45.
1093		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 35.1 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
1094		-	35.2cannabis flower from a mature plant for use as adult-use cannabis flower or for use in
1095		-	35.3adult-use cannabis products;
1096		-	35.4 (2) grow cannabis plants from seed or immature plant to mature plant and harvest
1097		-	35.5cannabis flower from a mature plant for use as medical cannabis flower or for use in medical
1098		-	35.6cannabinoid products;
1099		-	35.7 (3) make cannabis concentrate;
1100		-	35.8 (4) make hemp concentrate, including hemp concentrate with a delta-9
1101		-	35.9tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
1102		-	35.10 (5) manufacture artificially derived cannabinoids;
1103		-	35.11 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
1104		-	35.12hemp-derived consumer products for public consumption;
1105		-	35.13 (7) process medical cannabinoid products;
1106		-	35.14 (8) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis
1107		-	35.15products, lower-potency hemp edibles, and hemp-derived consumer products from a cannabis
1108		-	35.16microbusiness, another cannabis mezzobusiness, a cannabis cultivator, a cannabis
1109		-	35.17manufacturer, or a cannabis wholesaler, or a lower-potency hemp edible manufacturer;
1110		-	35.18 (9) purchase cannabis concentrate, hemp concentrate, and synthetically artificially derived
1111		-	35.19cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis
1112		-	35.20manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products,
1113		-	35.21lower-potency hemp edibles, or hemp-derived consumer products;
1114		-	35.22 (10) purchase hemp plant parts and propagules from a licensed hemp grower licensed
1115		-	35.23under chapter 18K;
1116		-	35.24 (11) purchase hemp concentrate from an industrial hemp processor licensed under chapter
1117		-	35.2518K;
1118		-	35.26 (12) package and label adult-use cannabis flower, adult-use cannabis products,
1119		-	35.27lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
1120		-	35.28 (13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
1121		-	35.29cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
1122		-	35.30other products authorized by law to other cannabis businesses and to customers; and
1123		-	35.31 (14) perform other actions approved by the office.
1124		-	35Sec. 45.
1125		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 36.1 Sec. 46. Minnesota Statutes 2024, section 342.29, subdivision 7, is amended to read:
1126		-	36.2 Subd. 7.Production of customer consumer products endorsement.A cannabis
1127		-	36.3mezzobusiness that manufactures edible cannabis products, lower-potency hemp products,
1128		-	36.4or hemp-derived consumer products must comply with the requirements in section 342.26,
1129		-	36.5subdivisions 2 and 4.
1130		-	36.6 Sec. 47. Minnesota Statutes 2024, section 342.30, subdivision 1, is amended to read:
1131		-	36.7 Subdivision 1.Authorized actions.A cannabis cultivator license entitles the license
1132		-	36.8holder to:
1133		-	36.9 (1) grow cannabis plants within the approved amount of space from seed or immature
1134		-	36.10plant to mature plant,;
1135		-	36.11 (2) harvest cannabis flower from a mature plant,;
1136		-	36.12 (3) package and label immature cannabis plants and seedlings and cannabis flower for
1137		-	36.13sale to other cannabis businesses,;
1138		-	36.14 (4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis
1139		-	36.15businesses;
1140		-	36.16 (5) transport cannabis flower to a cannabis manufacturer located on the same premises,;
1141		-	36.17and
1142		-	36.18 (6) perform other actions approved by the office.
1143		-	36.19Sec. 48. Minnesota Statutes 2024, section 342.32, subdivision 4, is amended to read:
1144		-	36.20 Subd. 4.Multiple licenses; limits.(a) A person, cooperative, or business holding a
1145		-	36.21cannabis retailer license may also hold a cannabis delivery service license and a cannabis
1146		-	36.22event organizer license.
1147		-	36.23 (b) Except as provided in paragraph (a) and subdivision 5, no person, cooperative, or
1148		-	36.24business holding a cannabis retailer license may own or operate any other cannabis business
1149		-	36.25or hemp business.
1150		-	36.26 (c) No person, cooperative, or business may hold a license to own or operate more than
1151		-	36.27one cannabis retail business in one city and three retail businesses in one county.
1152		-	36.28 (d) The office by rule may limit the number of cannabis retailer licenses a person,
1153		-	36.29cooperative, or business may hold.
1154		-	36Sec. 48.
1155		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 37.1 (e) For purposes of this subdivision, a restriction on the number or type of license a
1156		-	37.2business may hold applies to every cooperative member or every director, manager, and
1157		-	37.3general partner of a cannabis business.
1158		-	37.4 Sec. 49. Minnesota Statutes 2024, section 342.32, subdivision 5, is amended to read:
1159		-	37.5 Subd. 5.Municipal or county cannabis store.A city or county may establish, own,
1160		-	37.6and operate a municipal cannabis store subject to the restrictions in this chapter.
1161		-	37.7Notwithstanding any law to the contrary, a city or county that establishes, owns, or operates
1162		-	37.8a municipal cannabis store may also hold a lower-potency hemp edible retailer license.
1163		-	37.9 Sec. 50. Minnesota Statutes 2024, section 342.33, subdivision 1, is amended to read:
1164		-	37.10 Subdivision 1.Authorized actions.A cannabis wholesaler license entitles the license
1165		-	37.11holder to:
1166		-	37.12 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,
1167		-	37.13lower-potency hemp edibles, and hemp-derived consumer products from cannabis
1168		-	37.14microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
1169		-	37.15and cannabis microbusinesses lower-potency hemp edible manufacturers;
1170		-	37.16 (2) purchase hemp plant parts and propagules from industrial hemp growers licensed
1171		-	37.17under chapter 18K;
1172		-	37.18 (3) purchase hemp concentrate from an industrial hemp processor licensed under chapter
1173		-	37.1918K;
1174		-	37.20 (4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products,
1175		-	37.21lower-potency hemp edibles, and hemp-derived consumer products to cannabis
1176		-	37.22microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;
1177		-	37.23 (5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;
1178		-	37.24 (6) import hemp-derived consumer products and lower-potency hemp edibles that contain
1179		-	37.25hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or
1180		-	37.26hemp plant parts; and
1181		-	37.27 (7) perform other actions approved by the office.
1182		-	37.28Sec. 51. Minnesota Statutes 2024, section 342.40, subdivision 7, is amended to read:
1183		-	37.29 Subd. 7.Cannabis event sales.(a) Cannabis microbusinesses with a retail endorsement,
1184		-	37.30cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis
1185		-	37Sec. 51.
1186		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 38.1combination businesses operating a retail location, and lower-potency hemp edible retailers,
1187		-	38.2including the cannabis event organizer, may be authorized to sell cannabis plants, adult-use
1188		-	38.3cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived
1189		-	38.4consumer products to customers at a cannabis event.
1190		-	38.5 (b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,
1191		-	38.6lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must
1192		-	38.7take place in a retail area as designated in the premises diagram.
1193		-	38.8 (c) Authorized retailers may only conduct sales within their specifically assigned area.
1194		-	38.9 (d) Authorized retailers must verify the age of all customers pursuant to section 342.27,
1195		-	38.10subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis
1196		-	38.11flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer
1197		-	38.12products to an individual under 21 years of age.
1198		-	38.13 (e) Authorized retailers may display one sample of each type of cannabis plant, adult-use
1199		-	38.14cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived
1200		-	38.15consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis
1201		-	38.16products must be stored in a sample jar or display case and be accompanied by a label or
1202		-	38.17notice containing the information required to be affixed to the packaging or container
1203		-	38.18containing adult-use cannabis flower and adult-use cannabis products sold to customers. A
1204		-	38.19sample may not consist of more than eight grams of adult-use cannabis flower or adult-use
1205		-	38.20cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams
1206		-	38.21of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use
1207		-	38.22cannabis flower or adult-use cannabis product before purchase.
1208		-	38.23 (f) The notice requirements under section 342.27, subdivision 6, apply to authorized
1209		-	38.24retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,
1210		-	38.25and hemp-derived consumer products for sale at a cannabis event.
1211		-	38.26 (g) Authorized retailers may not:
1212		-	38.27 (1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp
1213		-	38.28edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
1214		-	38.29 (2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis
1215		-	38.30products, lower-potency hemp edibles, or hemp-derived consumer products than a customer
1216		-	38.31is legally permitted to possess;
1217		-	38.32 (3) sell medical cannabis flower or medical cannabinoid products; or
1218		-	38Sec. 51.
1219		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 39.1 (4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp
1220		-	39.2edibles, or hemp-derived consumer products; or
1221		-	39.3 (5) (4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,
1222		-	39.4lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
1223		-	39.5 (h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis
1224		-	39.6product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis
1225		-	39.7plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,
1226		-	39.8and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,
1227		-	39.9locked container that is not accessible to the public. Such items being stored at a cannabis
1228		-	39.10event shall not be left unattended.
1229		-	39.11 (i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,
1230		-	39.12lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis
1231		-	39.13event must comply with this chapter and rules adopted pursuant to this chapter regarding
1232		-	39.14the testing, packaging, and labeling of those items.
1233		-	39.15 (j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,
1234		-	39.16damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring
1235		-	39.17system.
1236		-	39.18Sec. 52. Minnesota Statutes 2024, section 342.40, is amended by adding a subdivision to
1237		-	39.19read:
1238		-	39.20 Subd. 7a.Cannabis sample products.(a) Notwithstanding any other provisions of law,
1239		-	39.21an authorized retailer may give away samples of cannabis plants, cannabis flower, cannabis
1240		-	39.22products, lower-potency hemp edibles, or hemp-derived consumer products during a cannabis
1241		-	39.23event. A label or notice containing the information required to be affixed to the packaging
1242		-	39.24or container containing cannabis flower, adult-use cannabis products, lower-potency hemp
1243		-	39.25edibles, or hemp-derived consumer products sold to customers must be displayed and
1244		-	39.26available for consumers.
1245		-	39.27 (b) Products given away as samples must not consist of more than:
1246		-	39.28 (1) one gram of adult-use cannabis flower or adult-use cannabis concentrate;
1247		-	39.29 (2) ten milligrams of tetrahydrocannabinol infused in an edible cannabis product; and
1248		-	39.30 (3) five milligrams of delta-9 tetrahydrocannabinol, five milligrams of cannabidiol, five
1249		-	39.31milligrams of cannabigerol, or any combination of those cannabinoids that does not exceed
1250		-	39.32the identified amounts in a lower-potency hemp edible.
1251		-	39Sec. 52.
1252		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 40.1 (c) Authorized retailers must not give away samples to an individual who is visibly
1253		-	40.2intoxicated.
1254		-	40.3 (d) Samples must be recorded in the statewide monitoring system.
1255		-	40.4 Sec. 53. Minnesota Statutes 2024, section 342.43, is amended by adding a subdivision to
1256		-	40.5read:
1257		-	40.6 Subd. 3.Exception; municipal or county licenses.Notwithstanding any law to the
1258		-	40.7contrary, a city or county that establishes, owns, or operates a municipal cannabis store may
1259		-	40.8also hold a lower-potency hemp edible retailer license.
1260		-	40.9 Sec. 54. Minnesota Statutes 2024, section 342.44, subdivision 1, is amended to read:
1261		-	40.10 Subdivision 1.Application; contents.(a) Except as otherwise provided in this
1262		-	40.11subdivision, the provisions of this chapter relating to license applications, license selection
1263		-	40.12criteria, general ownership disqualifications and requirements, and general operational
1264		-	40.13requirements do not apply to hemp businesses.
1265		-	40.14 (b) The office, by rule, shall establish forms and procedures for the processing of hemp
1266		-	40.15licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp
1267		-	40.16license shall include the following information, if applicable:
1268		-	40.17 (1) the name, address, and date of birth of the applicant;
1269		-	40.18 (2) the address and legal property description of the business;
1270		-	40.19 (3) proof of trade name registration;
1271		-	40.20 (4) certification that the applicant will comply with the requirements of this chapter
1272		-	40.21relating to the ownership and operation of a hemp business;
1273		-	40.22 (5) identification of one or more controlling persons or managerial employees as agents
1274		-	40.23who shall be responsible for dealing with the office on all matters; and
1275		-	40.24 (6) a statement that the applicant agrees to respond to the office's supplemental requests
1276		-	40.25for information.
1277		-	40.26 (c) An applicant for a lower-potency hemp edible manufacturer license must submit an
1278		-	40.27attestation signed by a bona fide labor organization stating that the applicant has entered
1279		-	40.28into a labor peace agreement.
1280		-	40.29 (d) An application on behalf of a corporation or association shall be signed by at least
1281		-	40.30two officers or managing agents of that entity.
1282		-	40Sec. 54.
1283		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 41.1 Sec. 55. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to
1284		-	41.2read:
1285		-	41.3 Subd. 6.Building conditions.(a) A lower-potency hemp edible manufacturer must
1286		-	41.4comply with state and local building, fire, and zoning codes, requirements, and regulations.
1287		-	41.5 (b) A lower-potency hemp edible manufacturer must ensure that licensed premises are
1288		-	41.6maintained in a clean and sanitary condition and are free from infestation by insects, rodents,
1289		-	41.7or other pests.
1290		-	41.8 Sec. 56. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
1291		-	41.9 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure
1292		-	41.10that all lower-potency hemp edibles offered for sale comply with the limits on the amount
1293		-	41.11and types of cannabinoids that a lower-potency hemp edible can contain, including but not
1294		-	41.12limited to the requirement that lower-potency hemp edibles:
1295		-	41.13 (1) consist of servings that contain no more than five milligrams of delta-9
1296		-	41.14tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams
1297		-	41.15of cannabigerol, or any combination of those cannabinoids that does not exceed the identified
1298		-	41.16amounts, except that a lower-potency hemp edible that is intended to be consumed as a
1299		-	41.17beverage may contain no more than ten milligrams of delta-9 tetrahydrocannabinol in a
1300		-	41.18single-serving container;
1301		-	41.19 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids
1302		-	41.20per serving; and
1303		-	41.21 (3) do not contain an artificially derived cannabinoid other than delta-9
1304		-	41.22tetrahydrocannabinol.
1305		-	41.23 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a
1306		-	41.24single serving, the lower-potency hemp edible must indicate each serving by scoring,
1307		-	41.25wrapping, or other indicators that appear on the lower-potency hemp edible designating the
1308		-	41.26individual serving size. If it is not possible to indicate a single serving by scoring or use of
1309		-	41.27another indicator that appears on the product, the lower-potency hemp edible may not be
1310		-	41.28packaged in a manner that includes more than a single serving in each container, except
1311		-	41.29that a calibrated dropper, measuring spoon, or similar device for measuring a single serving
1312		-	41.30may be used for any edible cannabinoid products that are intended to be combined with
1313		-	41.31food or beverage products prior to consumption. If the lower-potency hemp edible is meant
1314		-	41.32to be consumed as a beverage, the beverage container may not contain more than two
1315		-	41Sec. 56.
1316		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 42.1servings per container. If the lower-potency hemp edible is meant to be consumed as a
1317		-	42.2beverage, the beverage container must not contain more than two servings.
1318		-	42.3 (c) Notwithstanding paragraph (b), any edible cannabinoid product that is intended to
1319		-	42.4be combined with food or beverage products before consumption must indicate the amount
1320		-	42.5of a single serving using one of the following methods:
1321		-	42.6 (1) the product must be packaged in individual servings;
1322		-	42.7 (2) the product must indicate a single serving by scoring or using another indicator that
1323		-	42.8appears on the product; or
1324		-	42.9 (3) the product must be sold with a calibrated dropper, measuring spoon, or similar
1325		-	42.10device for measuring a single serving.
1326		-	42.11 (c) (d) A single package containing multiple servings of a lower-potency hemp edible
1327		-	42.12must contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams
1328		-	42.13of cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids
1329		-	42.14that does not exceed the identified amounts.
1330		-	42.15Sec. 57. Minnesota Statutes 2024, section 342.51, subdivision 2, is amended to read:
1331		-	42.16 Subd. 2.Distribution requirements.(a) Prior to distribution of medical cannabis flower
1332		-	42.17or medical cannabinoid products to a person enrolled in the registry program, an employee
1333		-	42.18with a valid medical cannabis consultant certificate issued by the office or a licensed
1334		-	42.19pharmacist under chapter 151 of a cannabis business must:
1335		-	42.20 (1) review and confirm the patient's enrollment in the registry program;
1336		-	42.21 (2) verify that the person requesting the distribution of medical cannabis flower or
1337		-	42.22medical cannabinoid products is the patient, the patient's registered designated caregiver,
1338		-	42.23or the patient's parent, legal guardian, or spouse using the procedures established by the
1339		-	42.24office;
1340		-	42.25 (3) provide confirm that the patient had a consultation to the patient with (i) an employee
1341		-	42.26with a valid medical cannabis consultant certificate issued by the office; or (ii) an employee
1342		-	42.27who is a licensed pharmacist under chapter 151 to determine the proper medical cannabis
1343		-	42.28flower or medical cannabinoid product, dosage, and paraphernalia for the patient if required
1344		-	42.29under subdivision 3;
1345		-	42.30 (4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
1346		-	42.31product that includes recommended dosage requirements and other information as required
1347		-	42.32by the office; and
1348		-	42Sec. 57.
1349		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 43.1 (5) provide the patient with any other information required by the office.
1350		-	43.2 (b) A cannabis business with a medical cannabis retail endorsement may not deliver
1351		-	43.3medical cannabis flower or medical cannabinoid products to a person enrolled in the registry
1352		-	43.4program unless the cannabis business with a medical cannabis retail endorsement also holds
1353		-	43.5a cannabis delivery service license. The delivery of medical cannabis flower and medical
1354		-	43.6cannabinoid products are subject to the provisions of section 342.42.
1355		-	43.7 Sec. 58. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
1356		-	43.8read:
1357		-	43.9 Subd. 2a.Distribution to visiting patients.(a) A cannabis business with a medical
1358		-	43.10cannabis retail endorsement may distribute medical cannabis flower or medical cannabinoid
1359		-	43.11products to a visiting patient.
1360		-	43.12 (b) Before receiving a distribution of medical cannabis, a visiting patient must provide
1361		-	43.13to an employee of the cannabis business:
1362		-	43.14 (1) a valid medical cannabis registration verification card or equivalent document issued
1363		-	43.15by a Tribal medical cannabis program that indicates that the visiting patient is authorized
1364		-	43.16to use medical cannabis on Indian lands over which the Tribe has jurisdiction; and
1365		-	43.17 (2) a valid photographic identification card issued by the Tribal medical cannabis
1366		-	43.18program, a valid driver's license, or a valid state identification card.
1367		-	43.19 (c) Prior to the distribution of medical cannabis flower or medical cannabinoid products
1368		-	43.20to a visiting patient, an employee of a cannabis business must:
1369		-	43.21 (1) ensure that a patient-specific label has been applied to all medical cannabis flower
1370		-	43.22and medical cannabinoid products. The label must include the recommended dosage
1371		-	43.23requirements and other information required by the office; and
1372		-	43.24 (2) provide the patient with any other information required by the office.
1373		-	43.25 (d) For each transaction that involves a visiting patient, a cannabis business with a
1374		-	43.26medical cannabis retail endorsement must report to the office on a weekly basis:
1375		-	43.27 (1) the name of the visiting patient;
1376		-	43.28 (2) the name of the Tribal medical cannabis program in which the visiting patient is
1377		-	43.29enrolled;
1378		-	43.30 (3) the amount and dosages of medical cannabis distributed;
1379		-	43.31 (4) the chemical composition of the medical cannabis distributed; and
1380		-	43Sec. 58.
1381		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 44.1 (5) the tracking number assigned to the medical cannabis that was distributed to the
1382		-	44.2visiting patient.
1383		-	44.3 (e) A cannabis business with a medical cannabis retail endorsement may distribute
1384		-	44.4medical cannabis flower and medical cannabinoid products to a visiting patient in a motor
1385		-	44.5vehicle if:
1386		-	44.6 (1) an employee of the cannabis business with a medical cannabis retail endorsement
1387		-	44.7receives payment and distributes medical cannabis flower and medical cannabinoid products
1388		-	44.8in a designated zone that is as close as feasible to the front door of the facility where the
1389		-	44.9cannabis business is located;
1390		-	44.10 (2) the cannabis business with a medical cannabis retail endorsement ensures that the
1391		-	44.11receipt of payment and distribution of medical cannabis flower and medical cannabinoid
1392		-	44.12products are visually recorded by a closed-circuit television surveillance camera and provides
1393		-	44.13any other necessary security safeguards required by the office;
1394		-	44.14 (3) the cannabis business with a medical cannabis retail endorsement does not store
1395		-	44.15medical cannabis flower or medical cannabinoid products outside a restricted access area;
1396		-	44.16 (4) an employee of the cannabis business with a medical cannabis retail endorsement
1397		-	44.17transports medical cannabis flower and medical cannabinoid products from a restricted
1398		-	44.18access area to the designated zone for distribution to patients only after confirming that the
1399		-	44.19visiting patient has arrived in the designated zone;
1400		-	44.20 (5) the payment for and distribution of medical cannabis flower and medical cannabinoid
1401		-	44.21products to a patient only occurs after meeting the requirements in paragraph (b);
1402		-	44.22 (6) immediately following the distribution of medical cannabis flower or medical
1403		-	44.23cannabinoid products to a patient, an employee of the cannabis business with a medical
1404		-	44.24cannabis retail endorsement records the transaction in the statewide monitoring system; and
1405		-	44.25 (7) immediately following the distribution of medical cannabis flower and medical
1406		-	44.26cannabinoid products, an employee of the cannabis business with a medical cannabis retail
1407		-	44.27endorsement transports all payments received into the facility where the cannabis business
1408		-	44.28is located.
1409		-	44.29Sec. 59. Minnesota Statutes 2024, section 342.52, is amended by adding a subdivision to
1410		-	44.30read:
1411		-	44.31 Subd. 7a.Allowable delivery methods.A patient in the registry program may receive
1412		-	44.32medical cannabis flower and medical cannabinoid products. The office may approve
1413		-	44Sec. 59.
1414		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 45.1additional delivery methods to expand the types of products that qualify as medical
1415		-	45.2cannabinoid products.
1416		-	45.3 Sec. 60. Minnesota Statutes 2024, section 342.52, subdivision 9, is amended to read:
1417		-	45.4 Subd. 9.Registered designated caregiver.(a) The office must register a designated
1418		-	45.5caregiver for a patient if the patient requires assistance in administering medical cannabis
1419		-	45.6flower or medical cannabinoid products; obtaining medical cannabis flower, medical
1420		-	45.7cannabinoid products, or medical cannabis paraphernalia from a cannabis business with a
1421		-	45.8medical cannabis retail endorsement; or cultivating cannabis plants as permitted by section
1422		-	45.9342.09, subdivision 2.
1423		-	45.10 (b) In order to serve as a designated caregiver, a person must:
1424		-	45.11 (1) be at least 18 years of age;
1425		-	45.12 (2) agree to only possess the patient's medical cannabis flower and medical cannabinoid
1426		-	45.13products for purposes of assisting the patient; and
1427		-	45.14 (3) agree that if the application is approved, the person will not serve as a registered
1428		-	45.15designated caregiver for more than six registered patients at one time. Patients who reside
1429		-	45.16in the same residence count as one patient.
1430		-	45.17 (c) Nothing in this section shall be construed to prevent a registered designated caregiver
1431		-	45.18from being enrolled in the registry program as a patient and possessing and administering
1432		-	45.19medical cannabis flower or medical cannabinoid products as a patient.
1433		-	45.20 (d) Notwithstanding any law to the contrary, a registered designated caregiver approved
1434		-	45.21to assist a patient enrolled in the registry program with obtaining medical cannabis flower
1435		-	45.22may cultivate cannabis plants on behalf of one patient. A registered designated caregiver
1436		-	45.23may grow up to eight cannabis plants for the patient household that the registered designated
1437		-	45.24caregiver is approved to assist with obtaining medical cannabis flower. If a patient enrolled
1438		-	45.25in the registry program directs the patient's registered designated caregiver to cultivate
1439		-	45.26cannabis plants on behalf of the patient, the patient must assign the patient's right to cultivate
1440		-	45.27cannabis plants to the registered designated caregiver and the notify the office. A patient
1441		-	45.28who assigns the patient's right to cultivate cannabis plants to a registered caregiver is
1442		-	45.29prohibited from cultivating cannabis plants for personal use. Nothing in this paragraph limits
1443		-	45.30the right of a registered designated caregiver cultivating cannabis plants on behalf of a
1444		-	45.31patient enrolled in the registry program to also cultivate cannabis plants for personal use
1445		-	45.32pursuant to section 342.09, subdivision 2.
1446		-	45Sec. 60.
1447		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 46.1 Sec. 61. Minnesota Statutes 2024, section 342.56, subdivision 2, is amended to read:
1448		-	46.2 Subd. 2.Health care facilities.(a) Health care facilities licensed under chapter 144A;
1449		-	46.3hospice providers licensed under chapter 144A; boarding care homes or supervised living
1450		-	46.4facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities
1451		-	46.5owned, controlled, managed, or under common control with hospitals licensed under chapter
1452		-	46.6144; and other health care facilities licensed by the commissioner of health or the
1453		-	46.7commissioner of human services may adopt reasonable restrictions on the use of medical
1454		-	46.8cannabis flower or medical, cannabinoid products, lower-potency hemp edibles, hemp-derived
1455		-	46.9consumer products, or hemp-derived topical products by a patient enrolled in the registry
1456		-	46.10program who resides at or is actively receiving treatment or care at the facility. The
1457		-	46.11restrictions may include a provision that the facility must not store or maintain a patient's
1458		-	46.12supply of medical cannabis flower or medical cannabinoid products on behalf of the patient;
1459		-	46.13that a patient store the patient's supply of medical cannabis flower or medicinal, cannabinoid
1460		-	46.14products, lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived
1461		-	46.15topical products in a locked container accessible only to the patient, the patient's designated
1462		-	46.16caregiver, or the patient's parent, legal guardian, or spouse; that the facility is not responsible
1463		-	46.17for providing medical cannabis or hemp for patients; and that medical cannabis flower or
1464		-	46.18medical, cannabinoid products, lower-potency hemp edibles, hemp-derived consumer
1465		-	46.19products, or hemp-derived topical products are used only in a location specified by the
1466		-	46.20facility or provider. Nothing in this subdivision requires facilities and providers listed in
1467		-	46.21this subdivision to adopt such restrictions.
1468		-	46.22 (b) No facility or provider listed in this subdivision may unreasonably limit a patient's
1469		-	46.23access to or use of medical cannabis flower or medical cannabinoid products, lower-potency
1470		-	46.24hemp edibles, hemp-derived consumer products, or hemp-derived topical products to the
1471		-	46.25extent that such use is authorized under sections 342.51 to 342.59, or, in the case of a visiting
1472		-	46.26patient, authorized to use medical cannabis under the laws of their state of residence. No
1473		-	46.27facility or provider listed in this subdivision may prohibit a patient access to or use of medical
1474		-	46.28cannabis flower or medical cannabinoid products due solely to the fact that cannabis is a
1475		-	46.29controlled substance pursuant to the federal Uniform Controlled Substances Act. If a federal
1476		-	46.30regulatory agency, the United States Department of Justice, or the federal Centers for
1477		-	46.31Medicare and Medicaid Services takes one of the following actions, a facility or provider
1478		-	46.32may suspend compliance with this paragraph until the regulatory agency, the United States
1479		-	46.33Department of Justice, or the federal Centers for Medicare and Medicaid Services notifies
1480		-	46.34the facility or provider that it may resume permitting the use of medical cannabis flower or
1481		-	46.35medical, cannabinoid products, lower-potency hemp edibles, hemp-derived consumer
1482		-	46Sec. 61.
1483		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 47.1products, or hemp-derived topical products within the facility or in the provider's service
1484		-	47.2setting:
1485		-	47.3 (1) a federal regulatory agency or the United States Department of Justice initiates
1486		-	47.4enforcement action against a facility or provider related to the facility's compliance with
1487		-	47.5the medical cannabis program; or
1488		-	47.6 (2) a federal regulatory agency, the United States Department of Justice, or the federal
1489		-	47.7Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification
1490		-	47.8to the facility or provider that expressly prohibits the use of medical cannabis in health care
1491		-	47.9facilities or otherwise prohibits compliance with the medical cannabis program.
1492		-	47.10 (c) An employee or agent of a facility or provider listed in this subdivision or a person
1493		-	47.11licensed under chapter 144E is not violating this chapter or chapter 152 for the possession
1494		-	47.12of medical cannabis flower or medical cannabinoid products while carrying out employment
1495		-	47.13duties, including providing or supervising care to a patient enrolled in the registry program,
1496		-	47.14or distribution of medical cannabis flower or medical cannabinoid products to a patient
1497		-	47.15enrolled in the registry program who resides at or is actively receiving treatment or care at
1498		-	47.16the facility or from the provider with which the employee or agent is affiliated.
1499		-	47.17 (d) Nothing in this subdivision is intended to require a facility covered by this subdivision
1500		-	47.18to permit violations of sections 144.411 to 144.417.
1501		-	47.19Sec. 62. Minnesota Statutes 2024, section 342.57, is amended to read:
1502		-	47.20 342.57 PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.
1503		-	47.21 Subdivision 1.Presumption.(a) There is a presumption that a patient or other person
1504		-	47.22an individual enrolled in the registry program or a Tribal medical cannabis program patient
1505		-	47.23is engaged in the authorized use or possession of medical cannabis flower and medical
1506		-	47.24cannabinoid products.
1507		-	47.25 (b) This presumption may be rebutted by evidence that:
1508		-	47.26 (1) the use or possession of medical cannabis flower or medical cannabinoid products
1509		-	47.27by a patient or other person enrolled in the registry program was not for the purpose of
1510		-	47.28assisting with, treating, or alleviating the patient's qualifying medical condition or symptoms
1511		-	47.29associated with the patient's qualifying medical condition.; or
1512		-	47.30 (2) a Tribal medical cannabis program patient's use of medical cannabis was not for a
1513		-	47.31purpose authorized by the Tribal medical cannabis program.
1514		-	47Sec. 62.
1515		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 48.1 Subd. 2.Criminal and civil protections.(a) Subject to section 342.56, the following
1516		-	48.2are not violations of this chapter or chapter 152:
1517		-	48.3 (1) use or possession of medical cannabis flower, medical cannabinoid products, or
1518		-	48.4medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting
1519		-	48.5patient or a Tribal medical cannabis program patient to whom medical cannabis flower or
1520		-	48.6medical cannabinoid products are distributed under section 342.51, subdivision 5;
1521		-	48.7 (2) possession of medical cannabis flower, medical cannabinoid products, or medical
1522		-	48.8cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or
1523		-	48.9spouse of a patient enrolled in the registry program; or
1524		-	48.10 (3) possession of medical cannabis flower, medical cannabinoid products, or medical
1525		-	48.11cannabis paraphernalia by any person while carrying out duties required under sections
1526		-	48.12342.51 to 342.60.
1527		-	48.13 (b) The Office of Cannabis Management, members of the Cannabis Advisory Council,
1528		-	48.14Office of Cannabis Management employees, agents or contractors of the Office of Cannabis
1529		-	48.15Management, members of a Tribal medical cannabis board, a Tribal medical cannabis board's
1530		-	48.16staff, a Tribal medical cannabis board's agents or contractors, and health care practitioners
1531		-	48.17participating in the registry program are not subject to any civil penalties or disciplinary
1532		-	48.18action by the Board of Medical Practice, the Board of Nursing, or any business, occupational,
1533		-	48.19or professional licensing board or entity solely for participating in the registry program or
1534		-	48.20in a Tribal medical cannabis program either in a professional capacity or as a patient. A
1535		-	48.21pharmacist licensed under chapter 151 is not subject to any civil penalties or disciplinary
1536		-	48.22action by the Board of Pharmacy when acting in accordance with sections 342.51 to 342.60
1537		-	48.23either in a professional capacity or as a patient. Nothing in this section prohibits a professional
1538		-	48.24licensing board from taking action in response to a violation of law.
1539		-	48.25 (c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the
1540		-	48.26governor, or an employee of a state agency must not be held civilly or criminally liable for
1541		-	48.27any injury, loss of property, personal injury, or death caused by any act or omission while
1542		-	48.28acting within the scope of office or employment under sections 342.51 to 342.60.
1543		-	48.29 (d) Federal, state, and local law enforcement authorities are prohibited from accessing
1544		-	48.30the registry except when acting pursuant to a valid search warrant. Notwithstanding section
1545		-	48.3113.09, a violation of this paragraph is a gross misdemeanor.
1546		-	48.32 (e) Notwithstanding any law to the contrary, the office and employees of the office must
1547		-	48.33not release data or information about an individual contained in any report or document or
1548		-	48.34in the registry and must not release data or information obtained about a patient enrolled in
1549		-	48Sec. 62.
1550		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 49.1the registry program, except as provided in sections 342.51 to 342.60. Notwithstanding
1551		-	49.2section 13.09, a violation of this paragraph is a gross misdemeanor.
1552		-	49.3 (f) No information contained in a report or document, contained in the registry, or
1553		-	49.4obtained from a patient under sections 342.51 to 342.60 or from a Tribal medical cannabis
1554		-	49.5program patient may be admitted as evidence in a criminal proceeding, unless:
1555		-	49.6 (1) the information is independently obtained; or
1556		-	49.7 (2) admission of the information is sought in a criminal proceeding involving a criminal
1557		-	49.8violation of sections 342.51 to 342.60.
1558		-	49.9 (g) Possession of a registry verification or an application for enrollment in the registry
1559		-	49.10program and possession of a verification of enrollment or its equivalent issued by a Tribal
1560		-	49.11medical cannabis program or application for enrollment in a Tribal medical cannabis program
1561		-	49.12by a person entitled to possess the verification of enrollment or application for enrollment:
1562		-	49.13 (1) does not constitute probable cause or reasonable suspicion;
1563		-	49.14 (2) must not be used to support a search of the person or property of the person with a
1564		-	49.15registry verification or application to enroll in the registry program; and
1565		-	49.16 (3) must not subject the person or the property of the person to inspection by any
1566		-	49.17government agency.
1567		-	49.18 (h) A patient enrolled in the registry program or in a Tribal medical cannabis program
1568		-	49.19must not be subject to any penalty or disciplinary action by an occupational or a professional
1569		-	49.20licensing board solely because:
1570		-	49.21 (1) the patient is enrolled in the registry program or in a Tribal medical cannabis program;
1571		-	49.22or
1572		-	49.23 (2) the patient has a positive test for cannabis components or metabolites.
1573		-	49.24 Subd. 3.School enrollment; rental property.(a) No school may refuse to enroll or
1574		-	49.25otherwise penalize a patient or person enrolled in the registry program or a Tribal medical
1575		-	49.26cannabis program as a pupil solely because the patient or person is enrolled in the registry
1576		-	49.27program or a Tribal medical cannabis program, unless failing to do so would violate federal
1577		-	49.28law or regulations or cause the school to lose a monetary or licensing-related benefit under
1578		-	49.29federal law or regulations.
1579		-	49.30 (b) No landlord may refuse to lease to a patient or person enrolled in the registry program
1580		-	49.31or a Tribal medical cannabis program or otherwise penalize a patient or person enrolled in
1581		-	49.32the registry program or a Tribal medical cannabis program solely because the patient or
1582		-	49Sec. 62.
1583		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 50.1person is enrolled in the registry program or a Tribal medical cannabis program, unless
1584		-	50.2failing to do so would violate federal law or regulations or cause the landlord to lose a
1585		-	50.3monetary or licensing-related benefit under federal law or regulations.
1586		-	50.4 (c) A school must not refuse to enroll a patient as a pupil solely because cannabis is a
1587		-	50.5controlled substance according to the Uniform Controlled Substances Act, United States
1588		-	50.6Code, title 21, section 812.
1589		-	50.7 (d) A school must not penalize a pupil who is a patient solely because cannabis is a
1590		-	50.8controlled substance according to the Uniform Controlled Substances Act, United States
1591		-	50.9Code, title 21, section 812.
1592		-	50.10 (e) A landlord must not refuse to lease a property to a patient solely because cannabis
1593		-	50.11is a controlled substance according to the Uniform Controlled Substances Act, United States
1594		-	50.12Code, title 21, section 812.
1595		-	50.13 (f) A landlord must not otherwise penalize a patient solely because cannabis is a controlled
1596		-	50.14substance according to the Uniform Controlled Substances Act, United States Code, title
1597		-	50.1521, section 812.
1598		-	50.16 Subd. 4.Medical care.For purposes of medical care, including organ transplants, a
1599		-	50.17patient's use of medical cannabis flower or medical cannabinoid products according to
1600		-	50.18sections 342.51 to 342.60, or a Tribal medical cannabis program patient's use of medical
1601		-	50.19cannabis as authorized by a Tribal medical cannabis program, is considered the equivalent
1602		-	50.20of the authorized use of a medication used at the discretion of a health care practitioner and
1603		-	50.21does not disqualify a patient from needed medical care.
1604		-	50.22 Subd. 5.Employment.(a) Unless a failure to do so would violate federal or state law
1605		-	50.23or regulations or cause an employer to lose a monetary or licensing-related benefit under
1606		-	50.24federal law or regulations, an employer may not discriminate against a person in hiring,
1607		-	50.25termination, or any term or condition of employment, or otherwise penalize a person, if the
1608		-	50.26discrimination is based on:
1609		-	50.27 (1) the person's status as a patient or person an individual enrolled in the registry program;
1610		-	50.28or
1611		-	50.29 (2) the person's status as a Tribal medical cannabis program patient; or
1612		-	50.30 (2) (3) a patient's positive drug test for cannabis components or metabolites, unless the
1613		-	50.31patient used, possessed, sold, transported, or was impaired by medical cannabis flower or
1614		-	50.32a medical cannabinoid product on work premises, during working hours, or while operating
1615		-	50.33an employer's machinery, vehicle, or equipment.
1616		-	50Sec. 62.
1617		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 51.1 (b) An employee who is a patient in the registry program or a Tribal medical cannabis
1618		-	51.2program and whose employer requires the employee to undergo drug testing according to
1619		-	51.3section 181.953 may present the employee's registry verification or verification of enrollment
1620		-	51.4in a Tribal medical cannabis program as part of the employee's explanation under section
1621		-	51.5181.953, subdivision 6.
1622		-	51.6 Subd. 5a.Notice.An employer, a school, or a landlord must provide written notice to
1623		-	51.7a patient at least 14 days before the employer, school, or landlord takes an action against
1624		-	51.8the patient that is prohibited under subdivision 3 or 5. The written notice must cite the
1625		-	51.9specific federal law or regulation the employer, school, or landlord believes would be
1626		-	51.10violated if the employer, school, or landlord fails to take action. The notice must specify
1627		-	51.11which monetary or licensing-related benefit under federal law or regulations the employer,
1628		-	51.12school, or landlord would lose if the employer, school, or landlord fails to take action.
1629		-	51.13 Subd. 6.Custody; visitation; parenting time.A person must not be denied custody of
1630		-	51.14a minor child or visitation rights or parenting time with a minor child based solely on the
1631		-	51.15person's individual's status as a patient or person an individual enrolled in the registry
1632		-	51.16program or on the individual's status as a Tribal medical cannabis program patient. There
1633		-	51.17must be no presumption of neglect or child endangerment for conduct allowed under sections
1634		-	51.18342.51 to 342.60 or under a Tribal medical cannabis program, unless the person's individual's
1635		-	51.19behavior creates an unreasonable danger to the safety of the minor as established by clear
1636		-	51.20and convincing evidence.
1637		-	51.21 Subd. 6a.Retaliation prohibited.A school, a landlord, a health care facility, or an
1638		-	51.22employer must not retaliate against a patient for asserting the patient's rights or seeking
1639		-	51.23remedies under this section or section 152.32.
1640		-	51.24 Subd. 7.Action for damages; injunctive relief.In addition to any other remedy provided
1641		-	51.25by law, a patient or person an individual enrolled in the registry program or a Tribal medical
1642		-	51.26cannabis program may bring an action for damages against any person who violates
1643		-	51.27subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is liable to a patient or
1644		-	51.28person an individual enrolled in the registry program or a Tribal medical cannabis program
1645		-	51.29injured by the violation for the greater of the person's actual damages or a civil penalty of
1646		-	51.30$100 $1,000 and reasonable attorney fees. A patient may bring an action for injunctive relief
1647		-	51.31to prevent or end a violation of subdivisions 3 to 6a.
1648		-	51.32 Subd. 8.Sanctions restricted for those on parole, supervised release, or conditional
1649		-	51.33release.(a) This subdivision applies to an individual placed on parole, supervised release,
1650		-	51.34or conditional release.
1651		-	51Sec. 62.
1652		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 52.1 (b) The commissioner of corrections may not:
1653		-	52.2 (1) prohibit an individual from participating in the registry program or a Tribal medical
1654		-	52.3cannabis program as a condition of release; or
1655		-	52.4 (2) revoke an individual's parole, supervised release, or conditional release or otherwise
1656		-	52.5sanction an individual solely:
1657		-	52.6 (i) for participating in the registry program or a Tribal medical cannabis program; or
1658		-	52.7 (ii) for a positive drug test for cannabis components or metabolites.
1659		-	52.8 Sec. 63. Minnesota Statutes 2024, section 342.59, subdivision 2, is amended to read:
1660		-	52.9 Subd. 2.Allowable use; prohibited use.Data specified in subdivision 1 may be used
1661		-	52.10to comply with chapter 13, to comply with a request from the legislative auditor or the state
1662		-	52.11auditor in the performance of official duties, and for purposes specified in sections 342.47
1663		-	52.12342.51 to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis
1664		-	52.13Management or Division of Medical Cannabis must not be used for any purpose not specified
1665		-	52.14in sections 342.47 342.51 to 342.60 and must not be combined or linked in any manner
1666		-	52.15with any other list, dataset, or database. Data specified in subdivision 1 must not be shared
1667		-	52.16with any federal agency, federal department, or federal entity unless specifically ordered
1668		-	52.17to do so by a state or federal court.
1669		-	52.18Sec. 64. Minnesota Statutes 2024, section 342.61, subdivision 4, is amended to read:
1670		-	52.19 Subd. 4.Testing of samples; disclosures.(a) On a schedule determined by the office,
1671		-	52.20every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
1672		-	52.21manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
1673		-	52.22hemp edible manufacturer, or medical cannabis combination business shall make each batch
1674		-	52.23of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency
1675		-	52.24hemp edibles, or hemp-derived consumer products grown, manufactured, or imported by
1676		-	52.25the cannabis business or hemp business available to a cannabis testing facility.
1677		-	52.26 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
1678		-	52.27manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
1679		-	52.28hemp edible manufacturer, or medical cannabis combination business must disclose all
1680		-	52.29known information regarding pesticides, fertilizers, solvents, or other foreign materials,
1681		-	52.30including but not limited to catalysts used in creating artificially derived cannabinoids,
1682		-	52.31applied or added to the batch of cannabis flower, cannabis products, artificially derived
1683		-	52.32cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products subject to
1684		-	52Sec. 64.
1685		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 53.1testing. Disclosure must be made to the cannabis testing facility and must include information
1686		-	53.2about all applications by any person, whether intentional or accidental.
1687		-	53.3 (c) The A cannabis testing facility business shall select one or more representative
1688		-	53.4samples from each batch, test the samples for the presence of contaminants, and test the
1689		-	53.5samples for potency and homogeneity and to allow the cannabis flower, cannabis product,
1690		-	53.6artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer
1691		-	53.7product to be accurately labeled with its cannabinoid profile. Testing for contaminants must
1692		-	53.8include testing for residual solvents, foreign material, microbiological contaminants, heavy
1693		-	53.9metals, pesticide residue, mycotoxins, and any items identified pursuant to paragraph (b),
1694		-	53.10and may include testing for other contaminants. A cannabis testing facility must destroy or
1695		-	53.11return to the cannabis business or hemp business any part of the sample that remains after
1696		-	53.12testing.
1697		-	53.13Sec. 65. Minnesota Statutes 2024, section 342.63, subdivision 2, is amended to read:
1698		-	53.14 Subd. 2.Content of label; cannabis.All cannabis flower and hemp-derived consumer
1699		-	53.15products that consist of hemp plant parts sold to customers or patients must have affixed
1700		-	53.16on the packaging or container of the cannabis flower or hemp-derived consumer product a
1701		-	53.17label that contains at least the following information:
1702		-	53.18 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
1703		-	53.19cannabis cultivator, medical cannabis combination business, or industrial hemp grower
1704		-	53.20where the cannabis flower or hemp plant part was cultivated;
1705		-	53.21 (2) the net weight or volume of cannabis flower or hemp plant parts in the package or
1706		-	53.22container;
1707		-	53.23 (3) the batch number;
1708		-	53.24 (4) the cannabinoid profile;
1709		-	53.25 (5) a universal symbol established by the office indicating that the package or container
1710		-	53.26contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
1711		-	53.27hemp-derived consumer product;
1712		-	53.28 (6) verification that the cannabis flower or hemp plant part was tested according to
1713		-	53.29section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
1714		-	53.30standards;
1715		-	53.31 (7) information on the usage of the cannabis flower or hemp-derived consumer product;
1716		-	53.32 (8) the following statement: "Keep this product out of reach of children."; and
1717		-	53Sec. 65.
1718		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 54.1 (9) any other statements or information required by the office.
1719		-	54.2 Sec. 66. Minnesota Statutes 2024, section 342.63, subdivision 3, is amended to read:
1720		-	54.3 Subd. 3.Content of label; cannabinoid products.(a) All cannabis products,
1721		-	54.4lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other
1722		-	54.5than products subject to the requirements under subdivision 2, medical cannabinoid products,
1723		-	54.6and hemp-derived topical products sold to customers or patients must have affixed to the
1724		-	54.7packaging or container of the cannabis product a label that contains at least the following
1725		-	54.8information:
1726		-	54.9 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
1727		-	54.10cannabis cultivator, medical cannabis combination business, or industrial hemp grower that
1728		-	54.11cultivated the cannabis flower or hemp plant parts used in the cannabis product,
1729		-	54.12lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid
1730		-	54.13product;
1731		-	54.14 (2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
1732		-	54.15cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis
1733		-	54.16combination business, or industrial hemp grower that manufactured the cannabis concentrate,
1734		-	54.17hemp concentrate, or artificially derived cannabinoid and, if different, the name and license
1735		-	54.18number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,
1736		-	54.19lower-potency hemp edible manufacturer, or medical cannabis combination business that
1737		-	54.20manufactured the product;
1738		-	54.21 (3) the net weight or volume of the cannabis product, lower-potency hemp edible, or
1739		-	54.22hemp-derived consumer product in the package or container;
1740		-	54.23 (4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
1741		-	54.24product;
1742		-	54.25 (5) the batch number;
1743		-	54.26 (6) the serving size;
1744		-	54.27 (7) the cannabinoid profile per serving and in total;
1745		-	54.28 (8) a list of ingredients;
1746		-	54.29 (9) a universal symbol established by the office indicating that the package or container
1747		-	54.30contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
1748		-	54.31hemp-derived consumer product;
1749		-	54Sec. 66.
1750		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 55.1 (10) a warning symbol developed by the office in consultation with the commissioner
1751		-	55.2of health and the Minnesota Poison Control System that:
1752		-	55.3 (i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
1753		-	55.4 (ii) is in a highly visible color;
1754		-	55.5 (iii) includes a visual element that is commonly understood to mean a person should
1755		-	55.6stop;
1756		-	55.7 (iv) indicates that the product is not for children; and
1757		-	55.8 (v) includes the phone number of the Minnesota Poison Control System;
1758		-	55.9 (11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
1759		-	55.10consumer product, or medical cannabinoid product was tested according to section 342.61
1760		-	55.11and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
1761		-	55.12or medical cannabinoid product complies with the applicable standards;
1762		-	55.13 (12) information on the usage of the product;
1763		-	55.14 (13) the following statement: "Keep this product out of reach of children."; and
1764		-	55.15 (14) any other statements or information required by the office.
1765		-	55.16 (b) The office may by rule establish alternative labeling requirements for lower-potency
1766		-	55.17hemp edibles that are imported into the state if those requirements provide consumers with
1767		-	55.18information that is substantially similar to the information described in paragraph (a).
1768		-	55.19Sec. 67. Minnesota Statutes 2024, section 342.63, subdivision 5, is amended to read:
1769		-	55.20 Subd. 5.Content of label; hemp-derived topical products.(a) All hemp-derived topical
1770		-	55.21products sold to customers must have affixed to the packaging or container of the product
1771		-	55.22a label that contains at least the following information:
1772		-	55.23 (1) the manufacturer name, location, phone number, and website;
1773		-	55.24 (2) the name and address of the independent, accredited laboratory used by the
1774		-	55.25manufacturer to test the product;
1775		-	55.26 (3) the net weight or volume of the product in the package or container;
1776		-	55.27 (4) the type of topical product;
1777		-	55.28 (5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid,
1778		-	55.29derivative, or extract of hemp, per serving and in total;
1779		-	55.30 (6) a list of ingredients;
1780		-	55Sec. 67.
1781		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 56.1 (7) a statement that the product does not claim to diagnose, treat, cure, or prevent any
1782		-	56.2disease and that the product has not been evaluated or approved by the United States Food
1783		-	56.3and Drug Administration, unless the product has been so approved; and
1784		-	56.4 (8) any other statements or information required by the office.
1785		-	56.5 (b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided
1786		-	56.6through the use of a scannable barcode or matrix barcode that links to a page on a website
1787		-	56.7maintained by the manufacturer or distributor if that page contains all of the information
1788		-	56.8required by this subdivision.
1789		-	56.9 Sec. 68. Minnesota Statutes 2024, section 342.63, subdivision 6, is amended to read:
1790		-	56.10 Subd. 6.Additional information.(a) A cannabis microbusiness, cannabis mezzobusiness,
1791		-	56.11cannabis retailer, or medical cannabis combination business must provide customers and
1792		-	56.12patients with the following information:
1793		-	56.13 (1) factual information about impairment effects and the expected timing of impairment
1794		-	56.14effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
1795		-	56.15lower-potency hemp edibles, and hemp-derived consumer products;
1796		-	56.16 (2) a statement that customers and patients must not operate a motor vehicle or heavy
1797		-	56.17machinery while under the influence of cannabis flower, cannabis products, lower-potency
1798		-	56.18hemp edibles, and hemp-derived consumer products;
1799		-	56.19 (3) resources customers and patients may consult to answer questions about cannabis
1800		-	56.20flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
1801		-	56.21products, and any side effects and adverse effects;
1802		-	56.22 (4) contact information for the poison control center and a safety hotline or website for
1803		-	56.23customers to report and obtain advice about side effects and adverse effects of cannabis
1804		-	56.24flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
1805		-	56.25products;
1806		-	56.26 (5) substance use disorder treatment options; and
1807		-	56.27 (6) any other information specified by the office.
1808		-	56.28 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
1809		-	56.29cannabis combination business may include the information described in paragraph (a) by:
1810		-	56.30 (1) including the information on the label affixed to the packaging or container of cannabis
1811		-	56.31flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products
1812		-	56.32by:;
1813		-	56Sec. 68.
1814		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 57.1 (1) (2) posting the information in the premises of the cannabis microbusiness, cannabis
1815		-	57.2mezzobusiness, cannabis retailer, or medical cannabis combination business; or
1816		-	57.3 (2) (3) providing the information on a separate document or pamphlet provided to
1817		-	57.4customers or patients when the customer purchases cannabis flower, a cannabis product, a
1818		-	57.5lower-potency hemp edible, or a hemp-derived consumer product.
1819		-	57.6 Sec. 69. Minnesota Statutes 2024, section 342.66, subdivision 6, is amended to read:
1820		-	57.7 Subd. 6.Prohibitions.(a) A product sold to consumers under this section must not be
1821		-	57.8manufactured, marketed, distributed, or intended:
1822		-	57.9 (1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention
1823		-	57.10of disease in humans or other animals;
1824		-	57.11 (2) to affect the structure or any function of the bodies of humans or other animals;
1825		-	57.12 (3) to be consumed by combustion or vaporization of the product and inhalation of
1826		-	57.13smoke, aerosol, or vapor from the product;
1827		-	57.14 (4) to be consumed through chewing; or
1828		-	57.15 (5) to be consumed through injection or application to nonintact skin or a mucous
1829		-	57.16membrane or nonintact skin, except for products applied sublingually.
1830		-	57.17 (b) A product manufactured, marketed, distributed, or sold to consumers under this
1831		-	57.18section must not:
1832		-	57.19 (1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;
1833		-	57.20 (2) have been produced, prepared, packed, or held under unsanitary conditions where
1834		-	57.21the product may have been rendered injurious to health, or where the product may have
1835		-	57.22been contaminated with filth;
1836		-	57.23 (3) be packaged in a container that is composed, in whole or in part, of any poisonous
1837		-	57.24or deleterious substance that may render the contents injurious to health;
1838		-	57.25 (4) contain any additives or excipients that have been found by the United States Food
1839		-	57.26and Drug Administration to be unsafe for human or animal consumption;
1840		-	57.27 (5) contain a cannabinoid or an amount or percentage of cannabinoids that is different
1841		-	57.28than the information stated on the label;
1842		-	57.29 (6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid
1843		-	57.30approved by the office, in an amount that exceeds the standard established in subdivision
1844		-	57.312 3, paragraph (c); or
1845		-	57Sec. 69.
1846		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 58.1 (7) contain any contaminants for which testing is required by the office in amounts that
1847		-	58.2exceed the acceptable minimum standards established by the office.
1848		-	58.3 (c) No product containing any cannabinoid may be sold to any individual who is under
1849		-	58.421 years of age.
1850		-	58.5 Sec. 70. REPEALER.
1851		-	58.6 Minnesota Statutes 2024, sections 152.22, subdivision 2; and 342.151, subdivision 1,
1852		-	58.7are repealed.
1853		-	58Sec. 70.
1854		-	S2370-1 1st EngrossmentSF2370 REVISOR BD 152.22 DEFINITIONS.
1855		-	Subd. 2.Commissioner."Commissioner" means the commissioner of health.
1856		-	342.151 EMPLOYEES OF LICENSE HOLDERS.
1857		-	Subdivision 1.Definitions.For purposes of this section, a "license holder" includes a cannabis
1858		-	microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis
1859		-	retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis event organizer,
1860		-	cannabis delivery service, lower-potency hemp edible manufacturer, lower-potency hemp edible
1861		-	retailer, or medical cannabis combination business.
1862		-	1R
1863		-	APPENDIX
1864		-	Repealed Minnesota Statutes: S2370-1
	145	+	25-04139 as introduced02/19/25 REVISOR BD/MI